| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.934 | 0.002 | 0.947 | 5 Hydroxytryptamine uptake inhibitor | 0.934 0.002 DB01075 0.36 0.005 DBMET00087 0.947 0.002 DBMET00086 0.919 0.002 DBMET01200 0.808 0.003 DBMET01201 | DBMET00086 | |
| 0.844 | 0.004 | 0.844 | Spasmolytic | 0.203 0.117 DB14132 0.844 0.004 DB01075 0.8 0.004 DBMET00087 0.789 0.004 DBMET00086 0.676 0.007 DBMET01200 0.627 0.01 DBMET01201 | ||
| 0.724 | 0.005 | 0.724 | Vasodilator, peripheral | 0.306 0.094 DB14132 0.724 0.005 DB01075 0.485 0.031 DBMET00087 0.661 0.009 DBMET00086 0.51 0.026 DBMET01200 0.719 0.005 DBMET01201 | ||
| 0.721 | 0.003 | 0.721 | Anesthetic local | 0.721 0.003 DB01075 0.131 0.059 DBMET00087 0.62 0.004 DBMET00086 0.416 0.006 DBMET01200 0.325 0.01 DBMET01201 | ||
| 0.722 | 0.004 | 0.722 | Psychostimulant | 0.308 0.041 DB14132 0.722 0.004 DB01075 0.394 0.023 DBMET00087 0.685 0.004 DBMET00086 0.534 0.008 DBMET01200 0.399 0.023 DBMET01201 | ||
| 0.71 | 0.002 | 0.71 | Dopamine transporter inhibitor | 0.71 0.002 DB01075 0.236 0.004 DBMET00087 0.704 0.002 DBMET00086 0.703 0.002 DBMET01200 0.616 0.002 DBMET01201 | ||
| 0.705 | 0.008 | 0.705 | Aldehyde oxidase inhibitor | 0.705 0.008 DB01075 0.358 0.054 DBMET00086 0.488 0.034 DBMET01200 0.598 0.019 DBMET01201 | ||
| 0.693 | 0.005 | 0.693 | Histamine release inhibitor | 0.231 0.171 DB14132 0.693 0.005 DB01075 0.569 0.013 DBMET00087 0.566 0.014 DBMET00086 0.589 0.011 DBMET01200 0.683 0.005 DBMET01201 | ||
| 0.65 | 0.003 | 0.73 | Adrenaline uptake inhibitor | 0.65 0.003 DB01075 0.148 0.009 DBMET00087 0.73 0.002 DBMET00086 0.607 0.003 DBMET01200 0.43 0.004 DBMET01201 | DBMET00086 | |
| 0.643 | 0.003 | 0.643 | Sigma 1 receptor antagonist | 0.643 0.003 DB01075 0.52 0.004 DBMET00086 0.483 0.004 DBMET01200 0.14 0.005 DBMET01201 | ||
| 0.566 | 0.005 | 0.715 | Cyclic AMP phosphodiesterase inhibitor | 0.715 0.003 DB14132 0.566 0.005 DB01075 0.559 0.005 DBMET00087 0.355 0.024 DBMET00086 0.371 0.021 DBMET01200 0.368 0.022 DBMET01201 | DB14132 | |
| 0.526 | 0.004 | 0.526 | Sigma receptor antagonist | 0.526 0.004 DB01075 0.377 0.005 DBMET00086 0.333 0.005 DBMET01200 0.092 0.018 DBMET01201 | ||
| 0.515 | 0.004 | 0.515 | Nav1.3 sodium channel blocker | 0.515 0.004 DB01075 0.463 0.004 DBMET00086 0.289 0.01 DBMET01200 0.16 0.041 DBMET01201 | ||
| 0.496 | 0.005 | 0.496 | Nav1.2 sodium channel blocker | 0.496 0.005 DB01075 0.421 0.006 DBMET00086 0.356 0.01 DBMET01200 0.188 0.039 DBMET01201 | ||
| 0.487 | 0.004 | 0.487 | Acetylcholine M1 receptor antagonist | 0.158 0.067 DB14132 0.487 0.004 DB01075 0.184 0.05 DBMET00087 0.391 0.006 DBMET00086 0.344 0.009 DBMET01200 0.247 0.026 DBMET01201 | ||
| 0.484 | 0.005 | 0.484 | Cholinergic antagonist | 0.484 0.005 DB01075 0.257 0.02 DBMET00087 0.381 0.009 DBMET00086 0.31 0.013 DBMET01200 0.156 0.049 DBMET01201 | ||
| 0.494 | 0.016 | 0.494 | Vasodilator, coronary | 0.296 0.09 DB14132 0.494 0.016 DB01075 0.397 0.036 DBMET00087 0.457 0.022 DBMET00086 0.437 0.026 DBMET01200 0.375 0.044 DBMET01201 | ||
| 0.465 | 0.004 | 0.465 | Nav1.6 sodium channel blocker | 0.465 0.004 DB01075 0.39 0.004 DBMET00086 0.295 0.006 DBMET01200 0.166 0.038 DBMET01201 | ||
| 0.464 | 0.005 | 0.464 | Acetylcholine antagonist | 0.464 0.005 DB01075 0.229 0.024 DBMET00087 0.358 0.009 DBMET00086 0.283 0.015 DBMET01200 0.146 0.052 DBMET01201 | ||
| 0.466 | 0.019 | 0.466 | Cardiotonic | 0.253 0.08 DB14132 0.466 0.019 DB01075 0.349 0.039 DBMET00086 0.42 0.025 DBMET01200 0.244 0.087 DBMET01201 | ||
| 0.44 | 0.004 | 0.44 | Acetylcholine muscarinic antagonist | 0.44 0.004 DB01075 0.292 0.01 DBMET00087 0.317 0.008 DBMET00086 0.256 0.014 DBMET01200 0.173 0.033 DBMET01201 | ||
| 0.43 | 0.002 | 0.43 | Sphingomyelinase inhibitor | 0.43 0.002 DB01075 0.146 0.026 DBMET00087 0.337 0.003 DBMET00086 0.335 0.003 DBMET01200 0.207 0.008 DBMET01201 | ||
| 0.428 | 0.004 | 0.428 | Nav1.1 sodium channel blocker | 0.428 0.004 DB01075 0.345 0.005 DBMET00086 0.342 0.006 DBMET01200 0.228 0.014 DBMET01201 | ||
| 0.422 | 0.005 | 0.422 | Antihistaminic | 0.422 0.005 DB01075 0.276 0.012 DBMET00086 0.186 0.023 DBMET01200 0.119 0.043 DBMET01201 | ||
| 0.428 | 0.018 | 0.428 | Sigma receptor agonist | 0.428 0.018 DB01075 0.128 0.105 DBMET00086 | ||
| 0.411 | 0.005 | 0.411 | Histamine antagonist | 0.411 0.005 DB01075 0.267 0.012 DBMET00086 0.176 0.023 DBMET01200 0.104 0.046 DBMET01201 | ||
| 0.406 | 0.002 | 0.406 | Histamine N-methyltransferase inhibitor | 0.406 0.002 DB01075 0.134 0.021 DBMET00087 0.226 0.004 DBMET00086 0.308 0.003 DBMET01200 0.148 0.015 DBMET01201 | ||
| 0.382 | 0.005 | 0.382 | Calcium channel blocker | 0.382 0.005 DB01075 0.298 0.01 DBMET00086 0.255 0.016 DBMET01200 0.153 0.056 DBMET01201 | ||
| 0.391 | 0.023 | 0.391 | Anticonvulsant | 0.185 0.095 DB14132 0.391 0.023 DB01075 0.306 0.039 DBMET00086 0.269 0.05 DBMET01200 0.233 0.064 DBMET01201 | ||
| 0.365 | 0.005 | 0.367 | Alpha 2b adrenoreceptor antagonist | 0.365 0.005 DB01075 0.367 0.005 DBMET00086 0.268 0.012 DBMET01200 | DBMET00086 | |
| 0.359 | 0.004 | 0.359 | Dopamine uptake inhibitor | 0.359 0.004 DB01075 0.35 0.004 DBMET00086 0.218 0.005 DBMET01200 0.082 0.025 DBMET01201 | ||
| 0.381 | 0.026 | 0.381 | Vasodilator | 0.296 0.049 DB14132 0.381 0.026 DB01075 0.211 0.096 DBMET00087 0.339 0.036 DBMET00086 0.35 0.033 DBMET01200 0.254 0.067 DBMET01201 | ||
| 0.339 | 0.005 | 0.339 | Histamine H1 receptor antagonist | 0.339 0.005 DB01075 0.209 0.013 DBMET00086 0.172 0.019 DBMET01200 0.212 0.013 DBMET01201 | ||
| 0.348 | 0.024 | 0.348 | Anesthetic general | 0.348 0.024 DB01075 0.23 0.059 DBMET00086 0.249 0.051 DBMET01200 0.24 0.055 DBMET01201 | ||
| 0.353 | 0.032 | 0.353 | Potassium channel blocker | 0.353 0.032 DB01075 0.181 0.106 DBMET00086 | ||
| 0.376 | 0.056 | 0.604 | Antithrombotic | 0.376 0.056 DB01075 0.488 0.031 DBMET00087 0.351 0.064 DBMET00086 0.46 0.036 DBMET01200 0.604 0.016 DBMET01201 | DBMET01201 | |
| 0.321 | 0.004 | 0.324 | 5 Hydroxytryptamine 3E antagonist | 0.321 0.004 DB01075 0.324 0.004 DBMET00086 0.304 0.005 DBMET01200 0.178 0.11 DBMET01201 | DBMET00086 | |
| 0.313 | 0.004 | 0.388 | CYP2A6 inhibitor | 0.313 0.004 DB01075 0.297 0.004 DBMET00086 0.388 0.003 DBMET01200 0.121 0.026 DBMET01201 | DBMET01200 | |
| 0.372 | 0.074 | 0.423 | GABA C receptor rho-3 antagonist | 0.382 0.07 DB14132 0.372 0.074 DB01075 0.39 0.066 DBMET00086 0.423 0.052 DBMET01200 0.399 0.062 DBMET01201 | DBMET01200 | |
| 0.335 | 0.041 | 0.335 | HERG channel blocker | 0.335 0.041 DB01075 0.158 0.122 DBMET00086 | ||
| 0.298 | 0.021 | 0.298 | Lipocortins synthesis antagonist | 0.18 0.071 DB14132 0.298 0.021 DB01075 0.197 0.058 DBMET00087 0.182 0.069 DBMET00086 0.18 0.071 DBMET01200 0.204 0.054 DBMET01201 | ||
| 0.273 | 0.004 | 0.273 | Acetylcholine M4 receptor antagonist | 0.273 0.004 DB01075 0.136 0.013 DBMET00086 0.107 0.023 DBMET01200 | ||
| 0.382 | 0.117 | 0.434 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.324 0.181 DB14132 0.382 0.117 DB01075 0.434 0.073 DBMET00086 0.381 0.118 DBMET01200 0.345 0.156 DBMET01201 | DBMET00086 | |
| 0.321 | 0.072 | 0.408 | Calcium channel activator | 0.321 0.072 DB01075 0.408 0.022 DBMET00086 0.405 0.023 DBMET01200 0.318 0.074 DBMET01201 | DBMET00086 | |
| 0.375 | 0.127 | 0.375 | Caspase 9 stimulant | 0.375 0.127 DB01075 0.28 0.216 DBMET00086 0.294 0.201 DBMET01200 0.368 0.132 DBMET01201 | ||
| 0.295 | 0.051 | 0.295 | Potassium channel (Voltage-sensitive) blocker | 0.295 0.051 DB01075 0.152 0.135 DBMET00086 | ||
| 0.248 | 0.004 | 0.248 | Interferon agonist | 0.077 0.056 DB14132 0.248 0.004 DB01075 0.096 0.032 DBMET00087 0.137 0.012 DBMET00086 0.182 0.007 DBMET01200 0.133 0.013 DBMET01201 | ||
| 0.31 | 0.067 | 0.543 | 5 Hydroxytryptamine release stimulant | 0.31 0.067 DB01075 0.462 0.034 DBMET00086 0.543 0.021 DBMET01200 0.281 0.076 DBMET01201 | DBMET01200 | |
| 0.32 | 0.079 | 0.567 | Cholesterol antagonist | 0.201 0.164 DB14132 0.32 0.079 DB01075 0.434 0.043 DBMET00087 0.336 0.071 DBMET00086 0.313 0.083 DBMET01200 0.567 0.023 DBMET01201 | DBMET01201 | |
| 0.246 | 0.01 | 0.467 | Mediator release inhibitor | 0.246 0.01 DB01075 0.097 0.074 DBMET00087 0.246 0.01 DBMET00086 0.198 0.015 DBMET01200 0.467 0.004 DBMET01201 | DBMET01201 | |
| 0.245 | 0.01 | 0.245 | Calcium channel (voltage-sensitive) blocker | 0.245 0.01 DB01075 0.199 0.017 DBMET00086 0.163 0.028 DBMET01200 0.113 0.066 DBMET01201 | ||
| 0.236 | 0.005 | 0.236 | Acetylcholine M2 receptor antagonist | 0.236 0.005 DB01075 0.137 0.013 DBMET00086 0.1 0.021 DBMET01200 | ||
| 0.256 | 0.026 | 0.298 | MAP kinase kinase 3 inhibitor | 0.256 0.026 DB01075 0.255 0.027 DBMET00086 0.298 0.008 DBMET01200 0.235 0.048 DBMET01201 | DBMET01200 | |
| 0.238 | 0.009 | 0.273 | Arachidonic acid antagonist | 0.238 0.009 DB01075 0.178 0.056 DBMET00087 0.206 0.027 DBMET00086 0.216 0.02 DBMET01200 0.273 0.003 DBMET01201 | DBMET01201 | |
| 0.227 | 0.004 | 0.252 | Histamine H2 receptor antagonist | 0.227 0.004 DB01075 0.252 0.004 DBMET00086 0.162 0.008 DBMET01200 0.088 0.051 DBMET01201 | DBMET00086 | |
| 0.232 | 0.01 | 0.232 | Acetylcholine nicotinic antagonist | 0.232 0.01 DB01075 0.206 0.012 DBMET00086 0.161 0.018 DBMET01200 | ||
| 0.224 | 0.011 | 0.224 | Calcium antagonist | 0.224 0.011 DB01075 0.117 0.037 DBMET00086 0.136 0.027 DBMET01200 0.076 0.068 DBMET01201 | ||
| 0.237 | 0.023 | 0.237 | 5 Hydroxytryptamine 2 antagonist | 0.237 0.023 DB01075 0.191 0.033 DBMET00086 0.125 0.056 DBMET01200 | ||
| 0.211 | 0.004 | 0.211 | Acetylcholine M5 receptor antagonist | 0.211 0.004 DB01075 0.143 0.008 DBMET00086 0.106 0.016 DBMET01200 0.055 0.05 DBMET01201 | ||
| 0.212 | 0.009 | 0.305 | Dopamine agonist | 0.212 0.009 DB01075 0.284 0.005 DBMET00086 0.305 0.005 DBMET01200 0.069 0.045 DBMET01201 | DBMET01200 | |
| 0.229 | 0.027 | 0.68 | Alpha-N-acetylglucosaminidase inhibitor | 0.229 0.027 DB01075 0.295 0.017 DBMET00087 0.254 0.022 DBMET00086 0.273 0.019 DBMET01200 0.68 0.003 DBMET01201 | DBMET01201 | |
| 0.216 | 0.015 | 0.217 | Alpha 2 adrenoreceptor antagonist | 0.216 0.015 DB01075 0.217 0.015 DBMET00086 0.152 0.027 DBMET01200 | DBMET00086 | |
| 0.296 | 0.096 | 0.44 | Transcription factor NF kappa B inhibitor | 0.204 0.165 DB14132 0.296 0.096 DB01075 0.287 0.102 DBMET00087 0.335 0.082 DBMET00086 0.337 0.081 DBMET01200 0.44 0.055 DBMET01201 | DBMET01201 | |
| 0.217 | 0.018 | 0.217 | 5 Hydroxytryptamine 2A antagonist | 0.217 0.018 DB01075 0.149 0.028 DBMET00086 0.114 0.04 DBMET01200 | ||
| 0.21 | 0.013 | 0.21 | Alpha 2a adrenoreceptor antagonist | 0.21 0.013 DB01075 0.204 0.013 DBMET00086 0.174 0.018 DBMET01200 | ||
| 0.238 | 0.048 | 0.238 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.187 0.084 DB14132 0.238 0.048 DB01075 0.185 0.087 DBMET01200 0.22 0.058 DBMET01201 | ||
| 0.205 | 0.016 | 0.205 | 5 Hydroxytryptamine 2C antagonist | 0.205 0.016 DB01075 0.146 0.028 DBMET00086 0.112 0.039 DBMET01200 | ||
| 0.255 | 0.076 | 0.343 | 5 Hydroxytryptamine uptake stimulant | 0.255 0.076 DB01075 0.259 0.072 DBMET00086 0.343 0.028 DBMET01200 0.322 0.035 DBMET01201 | DBMET01200 | |
| 0.207 | 0.032 | 0.208 | ATPase inhibitor | 0.207 0.032 DB01075 0.208 0.031 DBMET00086 0.138 0.123 DBMET01200 0.181 0.056 DBMET01201 | DBMET00086 | |
| 0.179 | 0.008 | 0.179 | Acetylcholine M3 receptor antagonist | 0.179 0.008 DB01075 0.113 0.015 DBMET00086 0.085 0.024 DBMET01200 0.052 0.051 DBMET01201 | ||
| 0.187 | 0.017 | 0.259 | Adenylate kinase inhibitor | 0.187 0.017 DB01075 0.174 0.019 DBMET00087 0.129 0.037 DBMET00086 0.199 0.015 DBMET01200 0.259 0.009 DBMET01201 | DBMET01201 | |
| 0.196 | 0.027 | 0.196 | 5 Hydroxytryptamine 2B antagonist | 0.196 0.027 DB01075 0.125 0.056 DBMET00086 0.112 0.069 DBMET01200 | ||
| 0.172 | 0.008 | 0.172 | Calcium channel L-type blocker | 0.172 0.008 DB01075 0.134 0.013 DBMET00086 0.114 0.018 DBMET01200 0.085 0.034 DBMET01201 | ||
| 0.241 | 0.077 | 0.362 | Tyrosine 3 hydroxylase inhibitor | 0.179 0.178 DB14132 0.241 0.077 DB01075 0.249 0.069 DBMET00086 0.307 0.03 DBMET01200 0.362 0.013 DBMET01201 | DBMET01201 | |
| 0.255 | 0.091 | 0.313 | Insulysin inhibitor | 0.255 0.091 DB01075 0.271 0.078 DBMET00086 0.313 0.051 DBMET01200 0.244 0.102 DBMET01201 | DBMET01200 | |
| 0.189 | 0.03 | 0.292 | Alkylator | 0.189 0.03 DB01075 0.292 0.013 DBMET00087 0.185 0.031 DBMET00086 0.135 0.056 DBMET01200 0.149 0.047 DBMET01201 | DBMET00087 | |
| 0.204 | 0.046 | 0.23 | Antipruritic | 0.204 0.046 DB01075 0.215 0.04 DBMET00086 0.206 0.045 DBMET01200 0.23 0.032 DBMET01201 | DBMET01201 | |
| 0.179 | 0.023 | 0.179 | Calcium channel N-type blocker | 0.179 0.023 DB01075 0.171 0.027 DBMET00086 0.139 0.045 DBMET01200 0.105 0.085 DBMET01201 | ||
| 0.179 | 0.027 | 0.214 | Adenylate cyclase stimulant | 0.179 0.027 DB01075 0.127 0.109 DBMET00087 0.214 0.009 DBMET00086 0.191 0.018 DBMET01200 0.175 0.03 DBMET01201 | DBMET00086 | |
| 0.18 | 0.029 | 0.266 | Interleukin 4 antagonist | 0.18 0.029 DB01075 0.15 0.05 DBMET00087 0.17 0.035 DBMET00086 0.223 0.017 DBMET01200 0.266 0.011 DBMET01201 | DBMET01201 | |
| 0.181 | 0.032 | 0.181 | DNA intercalator | 0.181 0.032 DB01075 | ||
| 0.153 | 0.004 | 0.153 | Interferon inducer | 0.065 0.043 DB14132 0.153 0.004 DB01075 0.065 0.043 DBMET00087 0.108 0.01 DBMET00086 0.135 0.005 DBMET01200 0.107 0.01 DBMET01201 | ||
| 0.15 | 0.004 | 0.15 | Estrogen-related receptor beta agonist | 0.15 0.004 DB01075 0.104 0.02 DBMET00086 0.093 0.034 DBMET01200 0.11 0.015 DBMET01201 | ||
| 0.174 | 0.041 | 0.174 | 5 Hydroxytryptamine antagonist | 0.11 0.071 DB14132 0.174 0.041 DB01075 0.152 0.049 DBMET00086 0.106 0.074 DBMET01200 | ||
| 0.227 | 0.095 | 0.272 | DNA damaging | 0.227 0.095 DB01075 0.183 0.131 DBMET00087 0.223 0.098 DBMET00086 0.272 0.069 DBMET01200 | DBMET01200 | |
| 0.229 | 0.098 | 0.229 | 5 Hydroxytryptamine 1E antagonist | 0.229 0.098 DB01075 0.218 0.111 DBMET00086 0.172 0.164 DBMET01200 | ||
| 0.134 | 0.003 | 0.134 | GABA uptake inhibitor | 0.134 0.003 DB01075 0.04 0.025 DBMET00087 0.08 0.005 DBMET00086 0.113 0.003 DBMET01200 0.121 0.003 DBMET01201 | ||
| 0.14 | 0.01 | 0.156 | Acyl-CoA dehydrogenase inhibitor | 0.14 0.01 DB01075 0.078 0.023 DBMET00087 0.082 0.021 DBMET00086 0.11 0.014 DBMET01200 0.156 0.009 DBMET01201 | DBMET01201 | |
| 0.141 | 0.018 | 0.429 | Toll-Like receptor 3 antagonist | 0.141 0.018 DB01075 0.331 0.003 DBMET00086 0.429 0.002 DBMET01200 | DBMET01200 | |
| 0.177 | 0.056 | 0.33 | Diuretic | 0.192 0.047 DB14132 0.177 0.056 DB01075 0.231 0.034 DBMET00087 0.142 0.084 DBMET00086 0.157 0.072 DBMET01200 0.33 0.018 DBMET01201 | DBMET01201 | |
| 0.132 | 0.012 | 0.132 | T cell inhibitor | 0.132 0.012 DB01075 0.088 0.041 DBMET00086 0.094 0.031 DBMET01200 0.124 0.013 DBMET01201 | ||
| 0.14 | 0.024 | 0.14 | Acetylcholine release stimulant | 0.14 0.024 DB01075 0.118 0.051 DBMET00086 0.099 0.09 DBMET01200 | ||
| 0.152 | 0.038 | 0.182 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 DB01075 0.137 0.084 DBMET00087 0.143 0.064 DBMET00086 0.154 0.034 DBMET01200 0.182 0.006 DBMET01201 | DBMET01201 | |
| 0.215 | 0.101 | 0.375 | DNA synthesis inhibitor | 0.252 0.065 DB14132 0.215 0.101 DB01075 0.375 0.025 DBMET00087 0.203 0.119 DBMET00086 0.216 0.1 DBMET01200 0.298 0.044 DBMET01201 | DBMET00087 | |
| 0.149 | 0.039 | 0.196 | Vanilloid 1 agonist | 0.149 0.039 DB01075 0.194 0.013 DBMET00086 0.186 0.016 DBMET01200 0.196 0.013 DBMET01201 | DBMET01201 | |
| 0.143 | 0.036 | 0.146 | Photosensitizer | 0.143 0.036 DB01075 0.114 0.066 DBMET00086 0.133 0.043 DBMET01200 0.146 0.034 DBMET01201 | DBMET01201 | |
| 0.117 | 0.011 | 0.117 | Calcium channel T-type blocker | 0.117 0.011 DB01075 0.078 0.023 DBMET00086 0.083 0.021 DBMET01200 0.053 0.049 DBMET01201 | ||
| 0.141 | 0.036 | 0.261 | GABA C receptor antagonist | 0.141 0.036 DB01075 0.141 0.035 DBMET00086 0.261 0.005 DBMET01200 0.157 0.026 DBMET01201 | DBMET01200 | |
| 0.197 | 0.093 | 0.24 | Nitric-oxide synthase stimulant | 0.197 0.093 DB01075 0.222 0.058 DBMET00086 0.24 0.04 DBMET01200 0.234 0.045 DBMET01201 | DBMET01200 | |
| 0.14 | 0.037 | 0.147 | Alpha 2c adrenoreceptor antagonist | 0.14 0.037 DB01075 0.147 0.034 DBMET00086 0.112 0.056 DBMET01200 | DBMET00086 | |
| 0.119 | 0.02 | 0.119 | Dopamine D1 antagonist | 0.119 0.02 DB01075 0.082 0.032 DBMET00086 0.058 0.052 DBMET01200 | ||
| 0.117 | 0.018 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 DB01075 0.085 0.046 DBMET00087 0.092 0.039 DBMET00086 0.118 0.017 DBMET01200 0.102 0.03 DBMET01201 | DBMET01200 | |
| 0.101 | 0.004 | 0.146 | Cytokine production stimulant | 0.101 0.004 DB01075 0.058 0.015 DBMET00087 0.099 0.004 DBMET00086 0.146 0.003 DBMET01200 0.072 0.006 DBMET01201 | DBMET01200 | |
| 0.123 | 0.028 | 0.181 | Glutamate (mGluR7) agonist | 0.123 0.028 DB01075 0.181 0.005 DBMET00086 0.142 0.015 DBMET01200 0.164 0.008 DBMET01201 | DBMET00086 | |
| 0.245 | 0.152 | 0.387 | Immunosuppressant | 0.245 0.152 DB01075 0.387 0.069 DBMET00087 0.21 0.186 DBMET00086 0.298 0.116 DBMET01200 0.364 0.079 DBMET01201 | DBMET00087 | |
| 0.096 | 0.006 | 0.096 | Squalene epoxidase inhibitor | 0.096 0.006 DB01075 0.066 0.016 DBMET00086 0.056 0.024 DBMET01200 | ||
| 0.154 | 0.068 | 0.201 | GABA C receptor rho-2 antagonist | 0.128 0.109 DB14132 0.154 0.068 DB01075 0.201 0.028 DBMET00086 0.16 0.061 DBMET01200 0.173 0.048 DBMET01201 | DBMET00086 | |
| 0.101 | 0.016 | 0.134 | Beta adrenoreceptor antagonist | 0.101 0.016 DB01075 0.134 0.008 DBMET00086 0.11 0.013 DBMET01200 0.103 0.015 DBMET01201 | DBMET00086 | |
| 0.131 | 0.047 | 0.181 | Aminopeptidase B inhibitor | 0.131 0.047 DB01075 0.105 0.062 DBMET00086 0.181 0.026 DBMET01200 0.179 0.027 DBMET01201 | DBMET01200 | |
| 0.148 | 0.064 | 0.148 | Cytokine production inhibitor | 0.148 0.064 DB01075 | ||
| 0.115 | 0.032 | 0.115 | 5 Hydroxytryptamine 1 antagonist | 0.115 0.032 DB01075 0.094 0.039 DBMET00086 | ||
| 0.098 | 0.016 | 0.131 | NMDA 2C receptor antagonist | 0.098 0.016 DB01075 0.07 0.033 DBMET00086 0.131 0.009 DBMET01200 0.098 0.017 DBMET01201 | DBMET01200 | |
| 0.123 | 0.041 | 0.255 | UDP-glucose 4-epimerase inhibitor | 0.123 0.041 DB01075 0.196 0.019 DBMET00087 0.11 0.051 DBMET00086 0.141 0.032 DBMET01200 0.255 0.013 DBMET01201 | DBMET01201 | |
| 0.121 | 0.04 | 0.18 | Creatine kinase inhibitor | 0.121 0.04 DB01075 0.134 0.032 DBMET01200 0.18 0.014 DBMET01201 | DBMET01201 | |
| 0.118 | 0.037 | 0.145 | MAP kinase kinase 1 inhibitor | 0.118 0.037 DB01075 0.13 0.026 DBMET00086 0.145 0.018 DBMET01200 | DBMET01200 | |
| 0.085 | 0.005 | 0.085 | 5 Hydroxytryptamine 1D agonist | 0.085 0.005 DB01075 0.069 0.006 DBMET00086 0.045 0.012 DBMET01200 | ||
| 0.135 | 0.055 | 0.345 | Adenylate cyclase inhibitor | 0.345 0.01 DB14132 0.135 0.055 DB01075 0.112 0.074 DBMET00086 0.118 0.069 DBMET01200 | DB14132 | |
| 0.11 | 0.03 | 0.11 | Bromodomain-containing protein 2 inhibitor | 0.11 0.03 DB01075 0.095 0.047 DBMET00086 0.086 0.063 DBMET01200 | ||
| 0.119 | 0.039 | 0.119 | Prolactin inhibitor | 0.119 0.039 DB01075 0.083 0.077 DBMET01200 0.098 0.057 DBMET01201 | ||
| 0.093 | 0.014 | 0.093 | Histamine H3 receptor antagonist | 0.093 0.014 DB01075 0.067 0.02 DBMET00086 0.042 0.032 DBMET01200 | ||
| 0.161 | 0.086 | 0.224 | Phospholipase C inhibitor | 0.161 0.086 DB01075 0.157 0.093 DBMET00087 0.188 0.053 DBMET01200 0.224 0.032 DBMET01201 | DBMET01201 | |
| 0.087 | 0.012 | 0.087 | Ca(v)3.2 blocker | 0.087 0.012 DB01075 0.065 0.029 DBMET00086 0.061 0.037 DBMET01200 | ||
| 0.117 | 0.043 | 0.134 | Anabolic | 0.117 0.043 DB01075 0.089 0.08 DBMET00086 0.102 0.06 DBMET01200 0.134 0.028 DBMET01201 | DBMET01201 | |
| 0.093 | 0.02 | 0.108 | Phospholipase D inhibitor | 0.093 0.02 DB01075 0.108 0.01 DBMET00086 0.069 0.056 DBMET01200 0.068 0.057 DBMET01201 | DBMET00086 | |
| 0.091 | 0.018 | 0.091 | 5 Hydroxytryptamine 6 antagonist | 0.091 0.018 DB01075 0.073 0.027 DBMET00086 0.067 0.031 DBMET01200 | ||
| 0.148 | 0.076 | 0.354 | Phospholipase A2 inhibitor | 0.148 0.076 DB01075 0.141 0.085 DBMET00087 0.13 0.1 DBMET00086 0.231 0.029 DBMET01200 0.354 0.008 DBMET01201 | DBMET01201 | |
| 0.14 | 0.069 | 0.14 | Toll-Like receptor 9 antagonist | 0.14 0.069 DB01075 0.12 0.085 DBMET00086 | ||
| 0.108 | 0.037 | 0.205 | NADH dehydrogenase inhibitor | 0.104 0.039 DB14132 0.108 0.037 DB01075 0.149 0.018 DBMET00087 0.093 0.053 DBMET00086 0.131 0.023 DBMET01200 0.205 0.01 DBMET01201 | DBMET01201 | |
| 0.134 | 0.063 | 0.141 | Antibacterial (Helicobacter pylori) | 0.134 0.063 DB01075 0.136 0.06 DBMET00086 0.141 0.055 DBMET01200 0.11 0.098 DBMET01201 | DBMET01200 | |
| 0.074 | 0.006 | 0.074 | Sigma 2 receptor antagonist | 0.074 0.006 DB01075 0.045 0.011 DBMET00086 0.025 0.02 DBMET01200 | ||
| 0.08 | 0.012 | 0.11 | 5 Hydroxytryptamine 1B agonist | 0.08 0.012 DB01075 0.11 0.005 DBMET00086 0.088 0.01 DBMET01200 | DBMET00086 | |
| 0.112 | 0.044 | 0.209 | Electrolyte absorption antagonist | 0.209 0.007 DB14132 0.112 0.044 DB01075 0.094 0.067 DBMET00086 0.115 0.041 DBMET01200 0.176 0.012 DBMET01201 | DB14132 | |
| 0.073 | 0.005 | 0.073 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.073 0.005 DB01075 | ||
| 0.14 | 0.074 | 0.15 | Heat shock protein 70 antagonist | 0.15 0.046 DB14132 0.14 0.074 DB01075 0.134 0.101 DBMET01200 0.139 0.077 DBMET01201 | DB14132 | |
| 0.106 | 0.042 | 0.426 | Triose-phosphate isomerase inhibitor | 0.106 0.042 DB01075 0.132 0.026 DBMET00087 0.094 0.054 DBMET00086 0.149 0.02 DBMET01200 0.426 0.003 DBMET01201 | DBMET01201 | |
| 0.084 | 0.02 | 0.099 | Beta 3 adrenoreceptor antagonist | 0.084 0.02 DB01075 0.099 0.015 DBMET00086 0.061 0.053 DBMET01200 0.073 0.03 DBMET01201 | DBMET00086 | |
| 0.159 | 0.096 | 0.484 | Succinate dehydrogenase inhibitor | 0.159 0.096 DB01075 0.153 0.107 DBMET00086 0.205 0.045 DBMET01200 0.484 0.003 DBMET01201 | DBMET01201 | |
| 0.096 | 0.034 | 0.096 | 5 Hydroxytryptamine 1A antagonist | 0.096 0.034 DB01075 0.08 0.04 DBMET00086 0.064 0.05 DBMET01200 | ||
| 0.094 | 0.032 | 0.094 | Estrogen receptor alpha antagonist | 0.094 0.032 DB01075 0.089 0.036 DBMET01201 | ||
| 0.071 | 0.01 | 0.092 | Histamine H2 receptor agonist | 0.071 0.01 DB01075 0.092 0.005 DBMET00086 0.09 0.005 DBMET01200 | DBMET00086 | |
| 0.083 | 0.022 | 0.083 | Exportin-1 inhibitor | 0.083 0.022 DB01075 0.081 0.023 DBMET01200 0.073 0.038 DBMET01201 | ||
| 0.266 | 0.206 | 0.468 | 5 Hydroxytryptamine release inhibitor | 0.266 0.206 DB01075 0.271 0.2 DBMET00086 0.384 0.089 DBMET01200 0.468 0.044 DBMET01201 | DBMET01201 | |
| 0.257 | 0.197 | 0.588 | Calcium channel L-type activator | 0.257 0.197 DB01075 0.588 0.007 DBMET00086 0.317 0.143 DBMET01200 0.38 0.095 DBMET01201 | DBMET00086 | |
| 0.074 | 0.014 | 0.129 | Alpha-mannosidase inhibitor | 0.074 0.014 DB01075 0.129 0.004 DBMET00087 0.066 0.02 DBMET00086 0.076 0.013 DBMET01200 0.081 0.011 DBMET01201 | DBMET00087 | |
| 0.086 | 0.027 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.086 0.027 DB01075 0.072 0.054 DBMET00086 0.099 0.014 DBMET01200 | DBMET01200 | |
| 0.07 | 0.012 | 0.088 | Histamine H4 receptor antagonist | 0.07 0.012 DB01075 0.074 0.01 DBMET00086 0.088 0.007 DBMET01200 | DBMET01200 | |
| 0.074 | 0.017 | 0.088 | Histamine agonist | 0.074 0.017 DB01075 0.088 0.011 DBMET00086 0.072 0.018 DBMET01200 | DBMET00086 | |
| 0.108 | 0.052 | 0.111 | Alpha adrenoreceptor antagonist | 0.108 0.052 DB01075 0.111 0.051 DBMET00086 | DBMET00086 | |
| 0.069 | 0.013 | 0.07 | Adenylate cyclase 1 inhibitor | 0.069 0.013 DB01075 0.07 0.012 DBMET00086 0.065 0.015 DBMET01200 | DBMET00086 | |
| 0.123 | 0.067 | 0.216 | DNA repair enzyme inhibitor | 0.216 0.007 DB14132 0.123 0.067 DB01075 0.118 0.076 DBMET00086 | DB14132 | |
| 0.182 | 0.126 | 0.327 | Peptidyltransferase inhibitor | 0.182 0.126 DB01075 0.327 0.017 DBMET00087 0.285 0.031 DBMET00086 0.274 0.036 DBMET01200 0.224 0.072 DBMET01201 | DBMET00087 | |
| 0.119 | 0.066 | 0.142 | Cholesterol synthesis inhibitor | 0.119 0.066 DB01075 0.142 0.049 DBMET01201 | DBMET01201 | |
| 0.125 | 0.072 | 0.21 | Cyclooxygenase 3 inhibitor | 0.125 0.072 DB01075 0.127 0.069 DBMET00087 0.118 0.08 DBMET00086 0.15 0.048 DBMET01200 0.21 0.015 DBMET01201 | DBMET01201 | |
| 0.134 | 0.08 | 0.304 | Lipid peroxidase inhibitor | 0.134 0.08 DB01075 0.304 0.018 DBMET00087 0.135 0.08 DBMET01201 | DBMET00087 | |
| 0.084 | 0.031 | 0.084 | Acetylcholine M5 receptor agonist | 0.084 0.031 DB01075 0.066 0.048 DBMET01200 | ||
| 0.094 | 0.042 | 0.167 | Adrenaline agonist | 0.094 0.042 DB01075 0.167 0.011 DBMET00086 0.116 0.027 DBMET01200 0.105 0.034 DBMET01201 | DBMET00086 | |
| 0.105 | 0.053 | 0.153 | Antiadrenergic | 0.105 0.053 DB01075 0.153 0.035 DBMET00086 | DBMET00086 | |
| 0.107 | 0.056 | 0.107 | Gastric antisecretory | 0.107 0.056 DB01075 0.107 0.056 DBMET00086 0.093 0.074 DBMET01201 | ||
| 0.101 | 0.053 | 0.147 | Adrenaline antagonist | 0.101 0.053 DB01075 0.147 0.035 DBMET00086 | DBMET00086 | |
| 0.174 | 0.126 | 0.174 | ErbB-1 antagonist | 0.174 0.126 DB01075 | ||
| 0.051 | 0.003 | 0.051 | Estrogen-related receptor gamma antagonist | 0.051 0.003 DB01075 0.04 0.005 DBMET00086 0.028 0.022 DBMET01200 0.028 0.02 DBMET01201 | ||
| 0.068 | 0.02 | 0.082 | Epithelial sodium channel blocker | 0.068 0.02 DB01075 0.068 0.02 DBMET00086 0.082 0.012 DBMET01200 | DBMET01200 | |
| 0.199 | 0.151 | 0.249 | Gastrin inhibitor | 0.199 0.151 DB01075 0.249 0.08 DBMET00086 0.241 0.089 DBMET01201 | DBMET00086 | |
| 0.072 | 0.026 | 0.072 | Acetylcholine muscarinic agonist | 0.072 0.026 DB01075 | ||
| 0.084 | 0.039 | 0.14 | Aminopeptidase I inhibitor | 0.084 0.039 DB01075 0.072 0.051 DBMET00086 0.107 0.025 DBMET01200 0.14 0.014 DBMET01201 | DBMET01201 | |
| 0.061 | 0.016 | 0.137 | Mannosidase inhibitor | 0.061 0.016 DB01075 0.137 0.004 DBMET00087 0.053 0.022 DBMET00086 0.074 0.01 DBMET01200 0.072 0.011 DBMET01201 | DBMET00087 | |
| 0.178 | 0.134 | 0.46 | Immunostimulant | 0.178 0.134 DB01075 0.46 0.035 DBMET00087 0.238 0.101 DBMET01200 0.258 0.093 DBMET01201 | DBMET00087 | |
| 0.064 | 0.022 | 0.07 | Nicotinic alpha3beta2 receptor antagonist | 0.064 0.022 DB01075 0.07 0.017 DBMET00086 | DBMET00086 | |
| 0.066 | 0.029 | 0.073 | Beta 2 adrenoreceptor agonist | 0.066 0.029 DB01075 0.073 0.014 DBMET00086 0.073 0.015 DBMET01200 0.067 0.025 DBMET01201 | DBMET01200 | |
| 0.071 | 0.034 | 0.091 | Alpha 1d adrenoreceptor antagonist | 0.071 0.034 DB01075 0.091 0.026 DBMET00086 0.058 0.042 DBMET01200 | DBMET00086 | |
| 0.093 | 0.056 | 0.101 | Glutamate release inhibitor | 0.093 0.056 DB01075 0.093 0.055 DBMET00086 0.1 0.043 DBMET01200 0.101 0.042 DBMET01201 | DBMET01201 | |
| 0.103 | 0.067 | 0.103 | Falcipain 3 inhibitor | 0.103 0.067 DB01075 | ||
| 0.065 | 0.03 | 0.132 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.065 0.03 DB01075 0.054 0.042 DBMET00087 0.053 0.043 DBMET00086 0.082 0.019 DBMET01200 0.132 0.01 DBMET01201 | DBMET01201 | |
| 0.05 | 0.015 | 0.057 | Diamine oxidase inhibitor | 0.05 0.015 DB01075 0.051 0.014 DBMET00086 0.057 0.011 DBMET01200 | DBMET01200 | |
| 0.101 | 0.066 | 0.133 | Carbonic anhydrase XV inhibitor | 0.101 0.066 DB01075 0.133 0.038 DBMET01200 0.094 0.077 DBMET01201 | DBMET01200 | |
| 0.057 | 0.023 | 0.057 | Acetylcholine M1 receptor agonist | 0.057 0.023 DB01075 | ||
| 0.065 | 0.03 | 0.076 | 5 Hydroxytryptamine 1 agonist | 0.065 0.03 DB01075 0.076 0.026 DBMET00086 | DBMET00086 | |
| 0.089 | 0.057 | 0.15 | Ornithine decarboxylase inhibitor | 0.089 0.057 DB01075 0.117 0.028 DBMET00086 0.141 0.014 DBMET01200 0.15 0.011 DBMET01201 | DBMET01201 | |
| 0.109 | 0.078 | 0.109 | Estrogen antagonist | 0.109 0.078 DB01075 | ||
| 0.097 | 0.067 | 0.174 | GABA C receptor rho-1 antagonist | 0.097 0.067 DB01075 0.135 0.029 DBMET00086 0.174 0.013 DBMET01200 0.143 0.024 DBMET01201 | DBMET01200 | |
| 0.098 | 0.069 | 0.328 | GABA C receptor agonist | 0.098 0.069 DB01075 0.105 0.062 DBMET00086 0.289 0.01 DBMET01200 0.328 0.008 DBMET01201 | DBMET01201 | |
| 0.055 | 0.028 | 0.071 | Glycine transporter 2 inhibitor | 0.055 0.028 DB01075 0.049 0.031 DBMET00086 0.066 0.022 DBMET01200 0.071 0.02 DBMET01201 | DBMET01201 | |
| 0.066 | 0.04 | 0.066 | Dopamine D3 antagonist | 0.066 0.04 DB01075 0.06 0.045 DBMET00086 | ||
| 0.123 | 0.097 | 0.435 | Peroxidase inhibitor | 0.123 0.097 DB01075 0.122 0.098 DBMET00086 0.335 0.031 DBMET01200 0.435 0.016 DBMET01201 | DBMET01201 | |
| 0.054 | 0.03 | 0.089 | Beta 2 adrenoreceptor antagonist | 0.054 0.03 DB01075 0.089 0.009 DBMET00086 0.075 0.014 DBMET01200 0.06 0.024 DBMET01201 | DBMET00086 | |
| 0.071 | 0.047 | 0.269 | Phosphofructokinase-1 inhibitor | 0.071 0.047 DB01075 0.135 0.021 DBMET00087 0.06 0.056 DBMET00086 0.111 0.028 DBMET01200 0.269 0.007 DBMET01201 | DBMET01201 | |
| 0.053 | 0.029 | 0.053 | Topoisomerase II beta inhibitor | 0.053 0.029 DB01075 | ||
| 0.068 | 0.045 | 0.258 | Leukotriene synthesis inhibitor | 0.068 0.045 DB01075 0.078 0.039 DBMET01200 0.258 0.004 DBMET01201 | DBMET01201 | |
| 0.041 | 0.019 | 0.076 | Glutamate (mGluR3) antagonist | 0.041 0.019 DB01075 0.05 0.012 DBMET01200 0.076 0.005 DBMET01201 | DBMET01201 | |
| 0.062 | 0.041 | 0.067 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.041 DB01075 0.067 0.035 DBMET00086 | DBMET00086 | |
| 0.076 | 0.055 | 0.076 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.076 0.055 DB01075 0.076 0.055 DBMET01201 | ||
| 0.05 | 0.03 | 0.12 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DB01075 0.054 0.025 DBMET00087 0.044 0.04 DBMET00086 0.055 0.023 DBMET01200 0.12 0.004 DBMET01201 | DBMET01201 | |
| 0.099 | 0.079 | 0.099 | Protein kinase C gamma inhibitor | 0.099 0.079 DB01075 0.098 0.08 DBMET01200 | ||
| 0.068 | 0.048 | 0.219 | Phenylalanine 4-hydroxylase inhibitor | 0.068 0.048 DB01075 0.113 0.02 DBMET00086 0.166 0.01 DBMET01200 0.219 0.006 DBMET01201 | DBMET01201 | |
| 0.179 | 0.161 | 0.187 | Neuropeptide Y2 antagonist | 0.179 0.161 DB01075 0.187 0.145 DBMET01200 | DBMET01200 | |
| 0.065 | 0.046 | 0.069 | Fibroblast growth factor 2 antagonist | 0.065 0.046 DB01075 0.069 0.042 DBMET00086 | DBMET00086 | |
| 0.035 | 0.017 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.017 DB01075 | ||
| 0.045 | 0.027 | 0.06 | Guanylate cyclase inhibitor | 0.045 0.027 DB01075 0.06 0.012 DBMET01201 | DBMET01201 | |
| 0.106 | 0.088 | 0.232 | Aldehyde dehydrogenase inhibitor | 0.106 0.088 DB01075 0.129 0.063 DBMET01200 0.232 0.021 DBMET01201 | DBMET01201 | |
| 0.055 | 0.037 | 0.119 | Thromboxane synthase inhibitor | 0.055 0.037 DB01075 0.058 0.03 DBMET00086 0.061 0.026 DBMET01200 0.119 0.005 DBMET01201 | DBMET01201 | |
| 0.063 | 0.045 | 0.063 | Calcium channel P-type blocker | 0.063 0.045 DB01075 | ||
| 0.048 | 0.03 | 0.048 | Farnesyltransferase inhibitor | 0.048 0.03 DB01075 0.047 0.03 DBMET01200 0.048 0.03 DBMET01201 | ||
| 0.054 | 0.037 | 0.171 | Leukotriene B4 antagonist | 0.054 0.037 DB01075 0.053 0.038 DBMET00087 0.051 0.042 DBMET01200 0.171 0.004 DBMET01201 | DBMET01201 | |
| 0.023 | 0.007 | 0.023 | Estrogen-related receptor gamma agonist | 0.023 0.007 DB01075 0.021 0.009 DBMET00086 | ||
| 0.044 | 0.029 | 0.052 | Histamine H1 receptor agonist | 0.044 0.029 DB01075 0.052 0.015 DBMET00086 0.05 0.018 DBMET01200 | DBMET00086 | |
| 0.045 | 0.03 | 0.055 | Beta adrenoreceptor agonist | 0.045 0.03 DB01075 0.055 0.011 DBMET00086 0.05 0.019 DBMET01200 0.051 0.017 DBMET01201 | DBMET00086 | |
| 0.04 | 0.025 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.025 DB01075 | ||
| 0.07 | 0.056 | 0.18 | Glutamate dehydrogenase inhibitor | 0.07 0.056 DB01075 0.091 0.036 DBMET00087 0.081 0.044 DBMET00086 0.122 0.022 DBMET01200 0.18 0.012 DBMET01201 | DBMET01201 | |
| 0.025 | 0.011 | 0.028 | Geranylgeranyltransferase I inhibitor | 0.025 0.011 DB01075 0.02 0.016 DBMET00086 0.026 0.01 DBMET01200 0.028 0.009 DBMET01201 | DBMET01201 | |
| 0.107 | 0.093 | 0.107 | Acetylcholinesterase inhibitor | 0.107 0.093 DB01075 | ||
| 0.058 | 0.045 | 0.182 | Carbamoyl phosphate synthetase inhibitor | 0.055 0.049 DB14132 0.058 0.045 DB01075 0.055 0.048 DBMET00087 0.053 0.051 DBMET00086 0.102 0.02 DBMET01200 0.182 0.008 DBMET01201 | DBMET01201 | |
| 0.072 | 0.058 | 0.072 | Potassium channel (Tandem pore domain) blocker | 0.072 0.058 DB01075 0.069 0.067 DBMET00086 0.071 0.059 DBMET01200 | ||
| 0.071 | 0.058 | 0.072 | Alpha 1 adrenoreceptor antagonist | 0.071 0.058 DB01075 0.072 0.058 DBMET00086 | DBMET00086 | |
| 0.027 | 0.014 | 0.03 | Acid ceramidase inhibitor | 0.027 0.014 DB01075 0.03 0.009 DBMET00086 | DBMET00086 | |
| 0.089 | 0.077 | 0.112 | Carbonic anhydrase III inhibitor | 0.089 0.077 DB01075 0.1 0.062 DBMET01200 0.112 0.051 DBMET01201 | DBMET01201 | |
| 0.028 | 0.017 | 0.028 | Urotensin II agonist | 0.028 0.017 DB01075 | ||
| 0.046 | 0.035 | 0.046 | Glycine transporter inhibitor | 0.046 0.035 DB01075 | ||
| 0.05 | 0.038 | 0.08 | NMDA 2A receptor antagonist | 0.05 0.038 DB01075 0.08 0.02 DBMET00086 0.073 0.023 DBMET01200 0.058 0.031 DBMET01201 | DBMET00086 | |
| 0.043 | 0.032 | 0.043 | Geranyltranstransferase inhibitor | 0.043 0.032 DB01075 | ||
| 0.062 | 0.052 | 0.062 | Neuronal nicotinic receptor antagonist | 0.062 0.052 DB01075 0.06 0.054 DBMET00086 | ||
| 0.027 | 0.017 | 0.038 | Integrin alpha2beta1 antagonist | 0.027 0.017 DB01075 0.024 0.023 DBMET00086 0.038 0.007 DBMET01201 | DBMET01201 | |
| 0.055 | 0.045 | 0.061 | 5 Hydroxytryptamine 5 antagonist | 0.055 0.045 DB01075 0.061 0.036 DBMET00086 | DBMET00086 | |
| 0.028 | 0.018 | 0.033 | Myristoyl transferase inhibitor | 0.028 0.018 DB01075 0.033 0.01 DBMET00086 | DBMET00086 | |
| 0.066 | 0.056 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.056 DB01075 | ||
| 0.028 | 0.018 | 0.028 | Hedgehog signaling activator | 0.028 0.018 DB01075 0.027 0.02 DBMET00086 | ||
| 0.141 | 0.131 | 0.141 | P-glycoprotein inhibitor | 0.141 0.131 DB01075 | ||
| 0.033 | 0.023 | 0.428 | Prostacyclin antagonist | 0.033 0.023 DB01075 0.037 0.02 DBMET00086 0.037 0.02 DBMET01200 0.428 0.003 DBMET01201 | DBMET01201 | |
| 0.037 | 0.028 | 0.078 | Retinoid X receptor antagonist | 0.037 0.028 DB01075 0.046 0.016 DBMET01200 0.078 0.003 DBMET01201 | DBMET01201 | |
| 0.034 | 0.025 | 0.068 | Retinoid X alpha receptor antagonist | 0.034 0.025 DB01075 0.041 0.014 DBMET01200 0.068 0.003 DBMET01201 | DBMET01201 | |
| 0.028 | 0.019 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.028 0.019 DB14132 0.028 0.019 DB01075 0.031 0.017 DBMET01200 0.042 0.011 DBMET01201 | DBMET01201 | |
| 0.036 | 0.028 | 0.052 | Integrin alpha2 antagonist | 0.036 0.028 DB01075 0.052 0.01 DBMET01201 | DBMET01201 | |
| 0.034 | 0.027 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DB01075 0.037 0.023 DBMET00086 0.036 0.025 DBMET01200 | DBMET00086 | |
| 0.089 | 0.084 | 0.306 | Ferrochelatase inhibitor | 0.152 0.037 DB14132 0.089 0.084 DB01075 0.158 0.034 DBMET01200 0.306 0.007 DBMET01201 | DBMET01201 | |
| 0.166 | 0.161 | 0.358 | Superoxide dismutase inhibitor | 0.166 0.161 DB01075 0.17 0.155 DBMET00086 0.358 0.035 DBMET01200 0.325 0.043 DBMET01201 | DBMET01200 | |
| 0.088 | 0.082 | 0.155 | Phosphodiesterase 6D inhibitor | 0.155 0.009 DB14132 0.088 0.082 DB01075 | DB14132 | |
| 0.058 | 0.053 | 0.081 | 5 Hydroxytryptamine 3 agonist | 0.081 0.026 DB14132 0.058 0.053 DB01075 | DB14132 | |
| 0.104 | 0.1 | 0.155 | Cathepsin H inhibitor | 0.104 0.1 DB01075 0.111 0.088 DBMET00086 0.155 0.043 DBMET01200 0.122 0.073 DBMET01201 | DBMET01200 | |
| 0.015 | 0.011 | 0.056 | Calcium-sensing receptor antagonist | 0.015 0.011 DB01075 0.027 0.007 DBMET00086 0.015 0.01 DBMET01200 0.056 0.005 DBMET01201 | DBMET01201 | |
| 0.049 | 0.046 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.046 DB01075 | ||
| 0.028 | 0.024 | 0.028 | Acetylcholine M4 receptor agonist | 0.028 0.024 DB01075 | ||
| 0.038 | 0.034 | 0.042 | Oxytocin agonist | 0.038 0.034 DB01075 0.041 0.031 DBMET00086 0.042 0.03 DBMET01200 | DBMET01200 | |
| 0.047 | 0.044 | 0.246 | Aconitate hydratase inhibitor | 0.047 0.044 DB01075 0.075 0.016 DBMET01200 0.246 0.003 DBMET01201 | DBMET01201 | |
| 0.05 | 0.048 | 0.062 | 5 Hydroxytryptamine 3 antagonist | 0.062 0.033 DB14132 0.05 0.048 DB01075 | DB14132 | |
| 0.049 | 0.046 | 0.049 | Alpha 1L adrenoreceptor antagonist | 0.049 0.046 DB01075 | ||
| 0.042 | 0.04 | 0.046 | Potassium channel Kv1.3 blocker | 0.042 0.04 DB01075 0.046 0.033 DBMET00086 0.044 0.036 DBMET01201 | DBMET00086 | |
| 0.061 | 0.059 | 0.061 | 5 Hydroxytryptamine 1F antagonist | 0.061 0.059 DB01075 | ||
| 0.072 | 0.072 | 0.089 | MAP kinase kinase 7 inhibitor | 0.074 0.066 DBMET00086 0.089 0.027 DBMET01200 | DBMET01200 | |
| 0.023 | 0.024 | 0.024 | Vanilloid 2 agonist | 0.024 0.021 DBMET01201 | DBMET01201 | |
| 0.051 | 0.052 | 0.201 | Biliverdin reductase inhibitor | 0.055 0.046 DB14132 0.068 0.034 DBMET00087 0.094 0.02 DBMET01200 0.201 0.005 DBMET01201 | DBMET01201 | |
| 0.049 | 0.05 | 0.079 | Glucosylceramidase inhibitor | 0.079 0.016 DBMET00087 0.052 0.043 DBMET00086 0.053 0.041 DBMET01200 | DBMET00087 | |
| 0.071 | 0.073 | 0.097 | Glycine receptor antagonist | 0.097 0.035 DBMET00087 0.08 0.056 DBMET01201 | DBMET00087 | |
| 0.017 | 0.02 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET00087 0.018 0.016 DBMET01200 0.018 0.017 DBMET01201 | DBMET00087 | |
| 0.047 | 0.05 | 0.08 | Beta 1 adrenoreceptor antagonist | 0.08 0.018 DBMET00086 0.049 0.048 DBMET01201 | DBMET00086 | |
| 0.136 | 0.139 | 0.28 | Non-steroidal antiinflammatory agent | 0.152 0.113 DBMET01200 0.28 0.033 DBMET01201 | DBMET01201 | |
| 0.046 | 0.05 | 0.396 | Alcohol oxidase inhibitor | 0.311 0.004 DBMET01200 0.396 0.004 DBMET01201 | DBMET01201 | |
| 0.026 | 0.031 | 0.042 | Cholesterol ester transfer protein antagonist | 0.042 0.011 DBMET01201 | DBMET01201 | |
| 0.141 | 0.146 | 0.238 | Insulin sensitizer | 0.156 0.125 DBMET00086 0.158 0.122 DBMET01200 0.238 0.042 DBMET01201 | DBMET01201 | |
| 0.095 | 0.101 | 0.122 | MAP kinase kinase inhibitor | 0.106 0.088 DBMET00086 0.122 0.072 DBMET01200 | DBMET01200 | |
| 0.081 | 0.088 | 0.103 | Urease inhibitor | 0.103 0.064 DBMET01200 0.088 0.08 DBMET01201 | DBMET01200 | |
| 0.149 | 0.156 | 0.155 | MAP kinase kinase 5 inhibitor | 0.155 0.134 DBMET00086 | DBMET00086 | |
| 0.016 | 0.024 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET01200 0.021 0.007 DBMET01201 | DBMET01201 | |
| 0.067 | 0.075 | 0.071 | Vanilloid 4 agonist | 0.071 0.061 DBMET00086 0.07 0.065 DBMET01201 | DBMET00086 | |
| 0.02 | 0.029 | 0.035 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 DBMET00086 0.026 0.016 DBMET01200 0.035 0.007 DBMET01201 | DBMET01201 | |
| 0.055 | 0.064 | 0.074 | HIV-1 reverse transcriptase inhibitor | 0.074 0.046 DBMET01201 | DBMET01201 | |
| 0.031 | 0.04 | 0.04 | Adenosine uptake inhibitor | 0.04 0.012 DB14132 | DB14132 | |
| 0.059 | 0.068 | 0.089 | Glutamate (mGluR7) antagonist | 0.089 0.018 DBMET01201 | DBMET01201 | |
| 0.013 | 0.022 | 0.02 | Cyclin T1 inhibitor | 0.02 0.011 DBMET01200 | DBMET01200 | |
| 0.031 | 0.041 | 0.043 | Toll-Like receptor 2 agonist | 0.037 0.033 DBMET00086 0.043 0.027 DBMET01200 0.037 0.033 DBMET01201 | DBMET01200 | |
| 0.087 | 0.099 | 0.223 | Mucolytic | 0.108 0.067 DBMET01200 0.223 0.009 DBMET01201 | DBMET01201 | |
| 0.093 | 0.105 | 0.135 | Microtubule formation inhibitor | 0.135 0.047 DBMET01201 | DBMET01201 | |
| 0.071 | 0.083 | 0.085 | MAO B inhibitor | 0.085 0.071 DBMET01200 | DBMET01200 | |
| 0.008 | 0.021 | 0.058 | Calcium-dependent phospholipase A2 inhibitor | 0.058 0.003 DBMET01201 | DBMET01201 | |
| 0.041 | 0.054 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.045 0.044 DBMET00086 0.059 0.016 DBMET01200 | DBMET01200 | |
| 0.062 | 0.075 | 0.121 | Glycine receptor agonist | 0.108 0.017 DBMET01200 0.121 0.012 DBMET01201 | DBMET01201 | |
| 0.076 | 0.089 | 0.116 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.072 DBMET00086 0.099 0.036 DBMET01200 0.116 0.019 DBMET01201 | DBMET01201 | |
| 0.015 | 0.028 | 0.024 | Dopamine autoreceptor agonist | 0.024 0.016 DBMET00086 | DBMET00086 | |
| 0.008 | 0.022 | 0.017 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 DBMET01200 0.017 0.006 DBMET01201 | DBMET01201 | |
| 0.081 | 0.095 | 0.107 | Nitric-oxide synthase inhibitor | 0.107 0.049 DBMET00086 | DBMET00086 | |
| 0.012 | 0.027 | 0.035 | Sodium/hydrogen exchanger inhibitor | 0.016 0.015 DBMET00086 0.035 0.004 DBMET01200 | DBMET01200 | |
| 0.023 | 0.038 | 0.036 | Renin inhibitor | 0.036 0.026 DBMET00086 | DBMET00086 | |
| 0.011 | 0.027 | 0.032 | Alpha 2a adrenoreceptor agonist | 0.032 0.005 DBMET00086 0.025 0.006 DBMET01200 | DBMET00086 | |
| 0.033 | 0.048 | 0.064 | Thymidine kinase inhibitor | 0.064 0.012 DB14132 | DB14132 | |
| 0.03 | 0.046 | 0.047 | Dopamine D2 agonist | 0.047 0.029 DBMET00086 0.041 0.034 DBMET01200 | DBMET00086 | |
| 0.022 | 0.04 | 0.033 | Purinergic P2Y15 antagonist | 0.027 0.024 DBMET00086 0.033 0.013 DBMET01200 | DBMET01200 | |
| 0.012 | 0.03 | 0.016 | Vitamin D receptor agonist | 0.016 0.012 DBMET01201 | DBMET01201 | |
| 0.087 | 0.106 | 0.102 | MAO inhibitor | 0.102 0.088 DBMET01200 | DBMET01200 | |
| 0.026 | 0.049 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.03 DBMET00086 | DBMET00086 | |
| 0.055 | 0.078 | 0.216 | Glutamate decarboxylase inhibitor | 0.127 0.019 DBMET01200 0.216 0.005 DBMET01201 | DBMET01201 | |
| 0.069 | 0.093 | 0.088 | MAO A inhibitor | 0.088 0.073 DBMET01200 | DBMET01200 | |
| 0.106 | 0.13 | 0.175 | Mannose-6-phosphate isomerase inhibitor | 0.175 0.046 DBMET01201 | DBMET01201 | |
| 0.157 | 0.182 | 0.377 | RNA-directed DNA polymerase inhibitor | 0.377 0.02 DB14132 0.182 0.13 DBMET01200 0.276 0.037 DBMET01201 | DB14132 | |
| 0.015 | 0.041 | 0.063 | Leukotriene B4 receptor 1 antagonist | 0.063 0.005 DBMET01201 | DBMET01201 | |
| 0.05 | 0.076 | 0.145 | Phosphodiesterase 1A inhibitor | 0.145 0.005 DB14132 | DB14132 | |
| 0.016 | 0.042 | 0.056 | Squalene synthetase inhibitor | 0.051 0.014 DBMET00087 0.056 0.013 DBMET01201 | DBMET01201 | |
| 0.011 | 0.038 | 0.022 | Alpha 2c adrenoreceptor agonist | 0.022 0.008 DBMET00086 0.017 0.015 DBMET01200 | DBMET00086 | |
| 0.063 | 0.09 | 0.078 | Opioid kappa receptor antagonist | 0.078 0.061 DBMET00086 | DBMET00086 | |
| 0.036 | 0.063 | 0.055 | 5 Hydroxytryptamine 2 agonist | 0.055 0.032 DBMET01200 | DBMET01200 | |
| 0.014 | 0.042 | 0.023 | Lysophosphatidic acid 1 receptor antagonist | 0.023 0.011 DBMET01201 | DBMET01201 | |
| 0.144 | 0.172 | 0.26 | Interleukin agonist | 0.174 0.145 DBMET00086 0.238 0.088 DBMET01200 0.26 0.072 DBMET01201 | DBMET01201 | |
| 0.034 | 0.062 | 0.117 | Carbonic anhydrase XIV inhibitor | 0.117 0.007 DBMET00087 0.053 0.03 DBMET01200 0.05 0.032 DBMET01201 | DBMET00087 | |
| 0.008 | 0.038 | 0.034 | Ileal bile acid transport inhibitor | 0.034 0.004 DBMET00087 | DBMET00087 | |
| 0.046 | 0.076 | 0.085 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.052 DBMET01200 0.085 0.034 DBMET01201 | DBMET01201 | |
| 0.023 | 0.053 | 0.116 | Kinesin-like protein 1 inhibitor | 0.116 0.006 DBMET01200 | DBMET01200 | |
| 0.023 | 0.053 | 0.116 | Kinesin antagonist | 0.116 0.006 DBMET01200 | DBMET01200 | |
| 0.015 | 0.046 | 0.021 | Toll-Like receptor 8 agonist | 0.021 0.011 DBMET01200 | DBMET01200 | |
| 0.047 | 0.078 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.034 DBMET00086 0.053 0.048 DBMET01200 | DBMET00086 | |
| 0.008 | 0.039 | 0.022 | Carbonic anhydrase X inhibitor | 0.017 0.011 DBMET01200 0.022 0.007 DBMET01201 | DBMET01201 | |
| 0.008 | 0.039 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 DBMET01200 0.022 0.007 DBMET01201 | DBMET01201 | |
| 0.12 | 0.151 | 0.573 | Interleukin antagonist | 0.149 0.118 DBMET00086 0.573 0.014 DBMET01200 | DBMET01200 | |
| 0.021 | 0.052 | 0.084 | Fumarate hydratase inhibitor | 0.033 0.025 DBMET01200 0.084 0.007 DBMET01201 | DBMET01201 | |
| 0.049 | 0.081 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.046 DBMET01200 0.059 0.054 DBMET01201 | DBMET01200 | |
| 0.014 | 0.047 | 0.047 | Uridine phosphorylase inhibitor | 0.035 0.015 DBMET01200 0.047 0.009 DBMET01201 | DBMET01201 | |
| 0.046 | 0.079 | 0.167 | Leukotriene antagonist | 0.167 0.008 DBMET01201 | DBMET01201 | |
| 0.018 | 0.052 | 0.035 | Leukotriene A4 hydrolase inhibitor | 0.035 0.028 DBMET01201 | DBMET01201 | |
| 0.09 | 0.124 | 0.104 | Interleukin 8 antagonist | 0.104 0.088 DBMET00086 | DBMET00086 | |
| 0.032 | 0.065 | 0.098 | Ornithine carbamoyltransferase inhibitor | 0.084 0.02 DBMET01200 0.098 0.017 DBMET01201 | DBMET01201 | |
| 0.055 | 0.089 | 0.121 | Glutamate (mGluR6) antagonist | 0.082 0.022 DBMET01200 0.121 0.005 DBMET01201 | DBMET01201 | |
| 0.021 | 0.055 | 0.04 | Phosphoglycerate kinase inhibitor | 0.038 0.021 DBMET01200 0.04 0.02 DBMET01201 | DBMET01201 | |
| 0.117 | 0.152 | 0.211 | CF transmembrane conductance regulator agonist | 0.211 0.016 DB14132 0.14 0.096 DBMET01201 | DB14132 | |
| 0.024 | 0.059 | 0.052 | Glutamate (mGluR3) agonist | 0.034 0.018 DBMET01200 0.052 0.004 DBMET01201 | DBMET01201 | |
| 0.069 | 0.104 | 0.088 | mTOR complex 2 inhibitor | 0.088 0.051 DBMET00086 | DBMET00086 | |
| 0.051 | 0.088 | 0.121 | Cathepsin G inhibitor | 0.067 0.057 DBMET01200 0.121 0.027 DBMET01201 | DBMET01201 | |
| 0.042 | 0.079 | 0.059 | 5 Hydroxytryptamine agonist | 0.059 0.056 DBMET00086 | DBMET00086 | |
| 0.013 | 0.05 | 0.031 | Leukotriene B4 receptor 2 antagonist | 0.031 0.008 DBMET01201 | DBMET01201 | |
| 0.05 | 0.089 | 0.099 | Phosphodiesterase 1C inhibitor | 0.099 0.01 DB14132 | DB14132 | |
| 0.081 | 0.12 | 0.206 | Amylase inhibitor | 0.119 0.082 DBMET01200 0.206 0.042 DBMET01201 | DBMET01201 | |
| 0.025 | 0.065 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DBMET01200 | DBMET01200 | |
| 0.06 | 0.101 | 0.096 | Myeloperoxidase inhibitor | 0.079 0.069 DBMET00086 0.096 0.04 DBMET01200 | DBMET01200 | |
| 0.075 | 0.116 | 0.281 | Cystathionine beta-synthase inhibitor | 0.137 0.047 DB14132 0.094 0.084 DBMET01200 0.281 0.011 DBMET01201 | DBMET01201 | |
| 0.068 | 0.11 | 0.26 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.106 0.048 DBMET01200 0.26 0.009 DBMET01201 | DBMET01201 | |
| 0.041 | 0.082 | 0.075 | Alpha 2 adrenoreceptor agonist | 0.075 0.027 DBMET00086 | DBMET00086 | |
| 0.014 | 0.057 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DBMET01200 0.021 0.019 DBMET01201 | DBMET01200 | |
| 0.01 | 0.052 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET01201 | DBMET01201 | |
| 0.036 | 0.079 | 0.047 | Bombesin 2 receptor antagonist | 0.047 0.038 DBMET01200 | DBMET01200 | |
| 0.071 | 0.114 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | 0.101 0.054 DBMET01200 0.093 0.067 DBMET01201 | DBMET01200 | |
| 0.039 | 0.083 | 0.06 | Carbonic anhydrase stimulant | 0.06 0.041 DBMET00086 0.059 0.041 DBMET01200 | DBMET00086 | |
| 0.079 | 0.124 | 0.138 | Beta amyloid protein antagonist | 0.104 0.084 DBMET00086 0.138 0.05 DBMET01200 | DBMET01200 | |
| 0.106 | 0.151 | 0.148 | Hemostatic | 0.148 0.07 DBMET01200 0.142 0.078 DBMET01201 | DBMET01200 | |
| 0.017 | 0.063 | 0.093 | 5-Alpha-reductase inhibitor | 0.093 0.011 DBMET01201 | DBMET01201 | |
| 0.063 | 0.109 | 0.174 | Check point kinase 2 inhibitor | 0.174 0.024 DBMET01200 | DBMET01200 | |
| 0.004 | 0.051 | 0.01 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DBMET01201 | DBMET01201 | |
| 0.019 | 0.066 | 0.04 | Farnesoid X receptor agonist | 0.04 0.024 DBMET01201 | DBMET01201 | |
| 0.03 | 0.078 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.035 DBMET01200 0.047 0.018 DBMET01201 | DBMET01201 | |
| 0.011 | 0.058 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.017 DBMET01200 | DBMET01200 | |
| 0.008 | 0.057 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 DB14132 | DB14132 | |
| 0.014 | 0.063 | 0.033 | Sodium/glucose cotransporter 2 inhibitor | 0.033 0.011 DBMET00087 0.026 0.019 DBMET01201 | DBMET00087 | |
| 0.016 | 0.066 | 0.042 | Thyroid hormone agonist | 0.024 0.023 DBMET01200 0.042 0.005 DBMET01201 | DBMET01201 | |
| 0.061 | 0.114 | 0.106 | Glutathione S-transferase inhibitor | 0.083 0.056 DBMET01200 0.106 0.032 DBMET01201 | DBMET01201 | |
| 0.032 | 0.086 | 0.139 | Argininosuccinate synthase inhibitor | 0.067 0.032 DBMET01200 0.139 0.013 DBMET01201 | DBMET01201 | |
| 0.011 | 0.067 | 0.035 | Arginase inhibitor | 0.035 0.027 DBMET01201 | DBMET01201 | |
| 0.028 | 0.084 | 0.041 | Vanilloid 3 antagonist | 0.041 0.019 DBMET01201 | DBMET01201 | |
| 0.084 | 0.139 | 0.162 | Toll-Like receptor 2 antagonist | 0.105 0.097 DBMET00086 0.136 0.063 DBMET01200 0.162 0.044 DBMET01201 | DBMET01201 | |
| 0.125 | 0.181 | 0.201 | Neurotrophic factor enhancer | 0.201 0.075 DBMET01201 | DBMET01201 | |
| 0.016 | 0.073 | 0.038 | Methionyl aminopeptidase 1 inhibitor | 0.038 0.014 DBMET01201 | DBMET01201 | |
| 0.041 | 0.098 | 0.087 | Purinergic P2X1 antagonist | 0.087 0.021 DBMET01201 | DBMET01201 | |
| 0.008 | 0.066 | 0.081 | Prostaglandin EP2 agonist | 0.081 0.004 DBMET01201 | DBMET01201 | |
| 0.02 | 0.078 | 0.038 | Alpha 1d adrenoreceptor agonist | 0.038 0.028 DBMET00086 0.036 0.031 DBMET01200 | DBMET00086 | |
| 0.03 | 0.088 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.072 0.013 DBMET01201 | DBMET01201 | |
| 0.087 | 0.146 | 0.109 | Toll-Like receptor antagonist | 0.109 0.104 DBMET00086 | DBMET00086 | |
| 0.007 | 0.067 | 0.045 | Prostaglandin H2 antagonist | 0.045 0.004 DBMET01201 | DBMET01201 | |
| 0.014 | 0.074 | 0.117 | Peroxisome proliferator-activated receptor delta agonist | 0.117 0.005 DBMET01201 | DBMET01201 | |
| 0.012 | 0.073 | 0.028 | Lysine carboxypeptidase inhibitor | 0.024 0.022 DBMET01200 0.028 0.018 DBMET01201 | DBMET01201 | |
| 0.012 | 0.073 | 0.03 | Prostaglandin F2 alpha agonist | 0.03 0.009 DBMET01201 | DBMET01201 | |
| 0.017 | 0.079 | 0.045 | Retinoid X alpha receptor agonist | 0.045 0.016 DBMET01201 | DBMET01201 | |
| 0.054 | 0.117 | 0.164 | Keratolytic | 0.091 0.037 DBMET01200 0.164 0.012 DBMET01201 | DBMET01201 | |
| 0.042 | 0.105 | 0.066 | Pregnane X receptor antagonist | 0.066 0.02 DBMET01201 | DBMET01201 | |
| 0.05 | 0.113 | 0.096 | GABA aminotransferase inhibitor | 0.089 0.036 DBMET01200 0.096 0.03 DBMET01201 | DBMET01201 | |
| 0.059 | 0.122 | 0.14 | Topoisomerase I inhibitor | 0.14 0.045 DBMET00087 | DBMET00087 | |
| 0.086 | 0.151 | 0.287 | Thrombolytic | 0.179 0.062 DBMET00087 0.264 0.03 DBMET01200 0.287 0.026 DBMET01201 | DBMET01201 | |
| 0.106 | 0.17 | 0.153 | Melanin inhibitor | 0.153 0.078 DBMET01201 | DBMET01201 | |
| 0.058 | 0.123 | 0.095 | GABA B receptor agonist | 0.092 0.023 DBMET01200 0.095 0.021 DBMET01201 | DBMET01201 | |
| 0.041 | 0.106 | 0.195 | Porphobilinogen synthase inhibitor | 0.117 0.029 DBMET01200 0.195 0.013 DBMET01201 | DBMET01201 | |
| 0.019 | 0.084 | 0.039 | Vascular adhesion protein 1 inhibitor | 0.039 0.026 DBMET01200 | DBMET01200 | |
| 0.003 | 0.069 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET01201 | DBMET01201 | |
| 0.033 | 0.099 | 0.09 | 5 Hydroxytryptamine 2A agonist | 0.09 0.019 DBMET01200 | DBMET01200 | |
| 0.028 | 0.095 | 0.057 | Kainate receptor agonist | 0.038 0.037 DBMET01200 0.057 0.008 DBMET01201 | DBMET01201 | |
| 0.053 | 0.12 | 0.078 | Carbonic anhydrase VI inhibitor | 0.074 0.065 DBMET01200 0.078 0.06 DBMET01201 | DBMET01201 | |
| 0.022 | 0.09 | 0.068 | Adenosine deaminase inhibitor | 0.068 0.015 DB14132 0.058 0.022 DBMET01201 | DB14132 | |
| 0.15 | 0.219 | 0.331 | Hypoxia-inducible factor 1 alpha inhibitor | 0.331 0.052 DB14132 0.181 0.177 DBMET01201 | DB14132 | |
| 0.012 | 0.081 | 0.027 | Retinoid X beta receptor antagonist | 0.027 0.005 DBMET01201 | DBMET01201 | |
| 0.052 | 0.121 | 0.118 | Phosphodiesterase VI inhibitor | 0.118 0.013 DB14132 | DB14132 | |
| 0.007 | 0.076 | 0.031 | Thromboxane A2 agonist | 0.031 0.003 DBMET01201 | DBMET01201 | |
| 0.062 | 0.132 | 0.223 | Expectorant | 0.124 0.048 DBMET00087 0.223 0.016 DBMET01201 | DBMET01201 | |
| 0.019 | 0.089 | 0.131 | Peroxisome proliferator-activated receptor alpha agonist | 0.131 0.008 DBMET01201 | DBMET01201 | |
| 0.039 | 0.11 | 0.099 | Transcription factor AP-1 inhibitor | 0.099 0.013 DB14132 | DB14132 | |
| 0.021 | 0.093 | 0.042 | Membrane dipeptidase inhibitor | 0.042 0.023 DBMET01201 | DBMET01201 | |
| 0.029 | 0.101 | 0.049 | Elastase inhibitor | 0.049 0.043 DBMET01201 | DBMET01201 | |
| 0.02 | 0.093 | 0.07 | Phosphorylase inhibitor | 0.07 0.02 DBMET00087 0.043 0.035 DBMET01201 | DBMET00087 | |
| 0.007 | 0.079 | 0.014 | Thyroid hormone alpha antagonist | 0.014 0.013 DBMET01201 | DBMET01201 | |
| 0.014 | 0.087 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 DBMET00087 0.024 0.023 DBMET01201 | DBMET00087 | |
| 0.024 | 0.101 | 0.058 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET01200 0.058 0.008 DBMET01201 | DBMET01201 | |
| 0.011 | 0.089 | 0.036 | HCV NS5B polymerase inhibitor | 0.036 0.017 DBMET01201 | DBMET01201 | |
| 0.021 | 0.102 | 0.108 | Thromboxane A2 antagonist | 0.108 0.006 DBMET01201 | DBMET01201 | |
| 0.103 | 0.184 | 0.164 | Interferon gamma antagonist | 0.164 0.063 DBMET01201 | DBMET01201 | |
| 0.005 | 0.088 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.012 DBMET01201 | DBMET01201 | |
| 0.04 | 0.123 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 DB14132 0.056 0.055 DBMET01200 | DB14132 | |
| 0.109 | 0.192 | 0.42 | Hypolipemic | 0.223 0.081 DBMET00087 0.42 0.022 DBMET01201 | DBMET01201 | |
| 0.006 | 0.091 | 0.088 | Prostaglandin E2 agonist | 0.088 0.004 DBMET01201 | DBMET01201 | |
| 0.036 | 0.122 | 0.128 | Phosphodiesterase 1B inhibitor | 0.128 0.009 DB14132 | DB14132 | |
| 0.015 | 0.101 | 0.046 | ATP citrate lysase inhibitor | 0.046 0.009 DBMET01201 | DBMET01201 | |
| 0.011 | 0.098 | 0.046 | Retinoid X receptor agonist | 0.046 0.02 DBMET01201 | DBMET01201 | |
| 0.003 | 0.091 | 0.018 | Glutamate (mGluR6) agonist | 0.018 0.005 DBMET01201 | DBMET01201 | |
| 0.021 | 0.109 | 0.065 | Leukocyte elastase inhibitor | 0.065 0.016 DBMET01201 | DBMET01201 | |
| 0.027 | 0.116 | 0.049 | Glutamate (mGluR4) antagonist | 0.041 0.035 DBMET01200 0.049 0.021 DBMET01201 | DBMET01201 | |
| 0.013 | 0.103 | 0.126 | Phosphodiesterase 6A inhibitor | 0.126 0.002 DB14132 | DB14132 | |
| 0.003 | 0.092 | 0.021 | Thromboxane agonist | 0.021 0.004 DBMET01201 | DBMET01201 | |
| 0.01 | 0.1 | 0.128 | Prostaglandin agonist | 0.128 0.004 DBMET01201 | DBMET01201 | |
| 0.029 | 0.12 | 0.068 | Myc inhibitor | 0.068 0.021 DBMET00086 | DBMET00086 | |
| 0.028 | 0.119 | 0.052 | Glutamate (mGluR group III) antagonist | 0.052 0.019 DBMET01201 | DBMET01201 | |
| 0.045 | 0.138 | 0.122 | Macrophage migration inhibitory factor inhibitor | 0.122 0.025 DBMET01201 | DBMET01201 | |
| 0.062 | 0.155 | 0.091 | D-Ala-D-Ala ligase inhibitor | 0.091 0.042 DBMET01201 | DBMET01201 | |
| 0.034 | 0.128 | 0.178 | Histidine decarboxylase inhibitor | 0.11 0.028 DBMET01200 0.178 0.015 DBMET01201 | DBMET01201 | |
| 0.085 | 0.179 | 0.169 | Cell wall synthesis inhibitor | 0.126 0.091 DBMET01200 0.169 0.048 DBMET01201 | DBMET01201 | |
| 0.013 | 0.107 | 0.041 | 5 Hydroxytryptamine 1A agonist | 0.041 0.037 DBMET00086 | DBMET00086 | |
| 0.022 | 0.118 | 0.118 | Thromboxane antagonist | 0.118 0.007 DBMET01201 | DBMET01201 | |
| 0.033 | 0.129 | 0.185 | Catalase inhibitor | 0.185 0.018 DBMET01201 | DBMET01201 | |
| 0.031 | 0.127 | 0.054 | Sphingosine kinase 2 inhibitor | 0.054 0.04 DBMET01200 | DBMET01200 | |
| 0.014 | 0.109 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 DBMET01201 | DBMET01201 | |
| 0.046 | 0.142 | 0.336 | Adenosine A3 receptor antagonist | 0.336 0.005 DB14132 | DB14132 | |
| 0.025 | 0.127 | 0.099 | NMDA receptor glycine site agonist | 0.099 0.017 DBMET01201 | DBMET01201 | |
| 0.021 | 0.123 | 0.048 | Antibiotic Aminoglycoside-like | 0.048 0.014 DBMET00087 | DBMET00087 | |
| 0.02 | 0.123 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.016 DBMET01201 | DBMET01201 | |
| 0.018 | 0.121 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.025 DBMET01200 | DBMET01200 | |
| 0.049 | 0.153 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.081 0.06 DBMET00086 | DBMET00086 | |
| 0.051 | 0.156 | 0.073 | MDM2 inhibitor | 0.073 0.03 DBMET01201 | DBMET01201 | |
| 0.017 | 0.123 | 0.046 | RNA-directed RNA polymerase inhibitor | 0.046 0.015 DBMET01201 | DBMET01201 | |
| 0.02 | 0.127 | 0.048 | Sphingosine 1-phosphate receptor agonist | 0.048 0.027 DBMET01201 | DBMET01201 | |
| 0.01 | 0.117 | 0.045 | Prostaglandin EP4 antagonist | 0.045 0.009 DBMET01201 | DBMET01201 | |
| 0.038 | 0.147 | 0.08 | Protein kinase B alpha inhibitor | 0.08 0.04 DBMET01200 | DBMET01200 | |
| 0.114 | 0.224 | 0.152 | Neurotensin receptor agonist | 0.14 0.128 DBMET00086 0.152 0.097 DBMET01200 0.149 0.104 DBMET01201 | DBMET01200 | |
| 0.169 | 0.279 | 0.301 | Analgesic | 0.269 0.167 DB14132 0.301 0.141 DBMET00086 | DBMET00086 | |
| 0.008 | 0.119 | 0.026 | Glutamate (mGluR1a) agonist | 0.026 0.011 DBMET01201 | DBMET01201 | |
| 0.053 | 0.165 | 0.217 | Phosphodiesterase I inhibitor | 0.217 0.009 DB14132 | DB14132 | |
| 0.015 | 0.128 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.016 DB14132 | DB14132 | |
| 0.022 | 0.137 | 0.051 | Maillard reaction inhibitor | 0.051 0.042 DBMET01200 | DBMET01200 | |
| 0.029 | 0.144 | 0.071 | Heparanase inhibitor | 0.071 0.011 DBMET00087 0.054 0.035 DBMET01201 | DBMET00087 | |
| 0.055 | 0.17 | 0.117 | 5 Hydroxytryptamine 3A agonist | 0.095 0.082 DB14132 0.117 0.059 DBMET01200 | DBMET01200 | |
| 0.019 | 0.135 | 0.048 | Liver X receptor alpha agonist | 0.048 0.021 DBMET01201 | DBMET01201 | |
| 0.015 | 0.13 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.035 DBMET01201 | DBMET01201 | |
| 0.039 | 0.156 | 0.071 | Leukotriene C antagonist | 0.071 0.013 DBMET01201 | DBMET01201 | |
| 0.033 | 0.151 | 0.097 | NMDA receptor agonist | 0.097 0.02 DBMET01201 | DBMET01201 | |
| 0.015 | 0.133 | 0.056 | Antimetabolite | 0.056 0.028 DB14132 | DB14132 | |
| 0.018 | 0.136 | 0.429 | Adenosine A1 receptor antagonist | 0.429 0.004 DB14132 | DB14132 | |
| 0.066 | 0.186 | 0.147 | DOPA decarboxylase inhibitor | 0.101 0.074 DBMET01200 0.147 0.023 DBMET01201 | DBMET01201 | |
| 0.123 | 0.243 | 0.317 | Lipoxygenase inhibitor | 0.317 0.063 DBMET01201 | DBMET01201 | |
| 0.048 | 0.169 | 0.167 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.061 DBMET01200 0.167 0.02 DBMET01201 | DBMET01201 | |
| 0.023 | 0.144 | 0.387 | Adenosine A2 receptor antagonist | 0.387 0.004 DB14132 | DB14132 | |
| 0.025 | 0.147 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 DBMET01201 | DBMET01201 | |
| 0.02 | 0.142 | 0.354 | Adenosine A2a receptor antagonist | 0.354 0.004 DB14132 | DB14132 | |
| 0.028 | 0.152 | 0.064 | Alpha adrenoreceptor agonist | 0.064 0.051 DBMET00086 | DBMET00086 | |
| 0.098 | 0.222 | 0.457 | Platelet aggregation inhibitor | 0.457 0.013 DBMET01201 | DBMET01201 | |
| 0.011 | 0.138 | 0.068 | Phosphodiesterase 6H inhibitor | 0.068 0.002 DB14132 | DB14132 | |
| 0.011 | 0.138 | 0.068 | Phosphodiesterase 6G inhibitor | 0.068 0.002 DB14132 | DB14132 | |
| 0.003 | 0.129 | 0.042 | Prostaglandin EP4 agonist | 0.042 0.005 DBMET01201 | DBMET01201 | |
| 0.037 | 0.168 | 0.086 | NMDA receptor antagonist | 0.086 0.059 DBMET01201 | DBMET01201 | |
| 0.073 | 0.205 | 0.171 | Protein kinase stimulant | 0.171 0.055 DBMET01201 | DBMET01201 | |
| 0.03 | 0.165 | 0.107 | Phosphodiesterase 6C inhibitor | 0.107 0.003 DB14132 | DB14132 | |
| 0.009 | 0.151 | 0.043 | Free fatty acid receptor 1 antagonist | 0.043 0.013 DBMET01201 | DBMET01201 | |
| 0.082 | 0.23 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.084 DB14132 0.116 0.106 DBMET01201 | DB14132 | |
| 0.014 | 0.162 | 0.339 | Adenosine A2b receptor antagonist | 0.339 0.003 DB14132 | DB14132 | |
| 0.003 | 0.153 | 0.021 | G-protein-coupled receptor 120 agonist | 0.021 0.009 DBMET01201 | DBMET01201 | |
| 0.033 | 0.184 | 0.075 | Protein kinase B beta inhibitor | 0.075 0.049 DBMET01200 | DBMET01200 | |
| 0.092 | 0.244 | 0.137 | Sphingosine 1-phosphate receptor 5 antagonist | 0.137 0.086 DBMET01201 | DBMET01201 | |
| 0.044 | 0.196 | 0.063 | Prolactin release inhibitor | 0.063 0.039 DB14132 | DB14132 | |
| 0.02 | 0.177 | 0.189 | Peroxisome proliferator-activated receptor gamma agonist | 0.189 0.007 DBMET01201 | DBMET01201 | |
| 0.038 | 0.195 | 0.106 | Alcohol dehydrogenase inhibitor | 0.106 0.046 DBMET01201 | DBMET01201 | |
| 0.044 | 0.201 | 0.079 | Caspase 7 inhibitor | 0.079 0.063 DB14132 | DB14132 | |
| 0.011 | 0.171 | 0.126 | Phosphodiesterase 6B inhibitor | 0.126 0.003 DB14132 | DB14132 | |
| 0.077 | 0.241 | 0.149 | DNA methyltransferase I inhibitor | 0.149 0.105 DB14132 0.14 0.115 DBMET01201 | DB14132 | |
| 0.144 | 0.309 | 0.551 | Antibacterial | 0.551 0.028 DBMET00087 0.264 0.164 DBMET01200 0.254 0.173 DBMET01201 | DBMET00087 | |
| 0.054 | 0.221 | 0.138 | Vanilloid agonist | 0.081 0.069 DBMET00086 0.138 0.013 DBMET01200 0.128 0.015 DBMET01201 | DBMET01200 | |
| 0.049 | 0.218 | 0.122 | Beta glucuronidase inhibitor | 0.122 0.044 DBMET00087 | DBMET00087 | |
| 0.008 | 0.181 | 0.063 | Urate transporter 1 inhibitor | 0.063 0.013 DB14132 0.045 0.022 DBMET01201 | DB14132 | |
| 0.083 | 0.258 | 0.198 | Tumour necrosis factor antagonist | 0.198 0.055 DB14132 | DB14132 | |
| 0.038 | 0.212 | 0.079 | Peroxisome proliferator-activated receptor gamma antagonist | 0.079 0.036 DBMET01201 | DBMET01201 | |
| 0.07 | 0.245 | 0.111 | Sphingosine 1-phosphate receptor 4 antagonist | 0.111 0.092 DBMET01201 | DBMET01201 | |
| 0.028 | 0.204 | 0.059 | CD45 antagonist | 0.059 0.022 DBMET01201 | DBMET01201 | |
| 0.037 | 0.217 | 0.059 | Lipocortins synthesis agonist | 0.059 0.039 DBMET00087 0.055 0.048 DBMET01201 | DBMET00087 | |
| 0.077 | 0.258 | 0.149 | DNA methylase inhibitor | 0.149 0.118 DB14132 0.146 0.121 DBMET01201 | DB14132 | |
| 0.112 | 0.294 | 0.191 | Transcription factor STAT3 inhibitor | 0.191 0.147 DBMET01200 | DBMET01200 | |
| 0.021 | 0.204 | 0.062 | Nitric oxide donor | 0.062 0.045 DBMET01201 | DBMET01201 | |
| 0.081 | 0.267 | 0.646 | Platelet antagonist | 0.218 0.089 DBMET01200 0.646 0.005 DBMET01201 | DBMET01201 | |
| 0.033 | 0.221 | 0.064 | Adenine nucleotide translocase inhibitor | 0.06 0.028 DBMET00087 0.064 0.021 DBMET01201 | DBMET01201 | |
| 0.029 | 0.22 | 0.121 | Protein kinase A inhibitor | 0.121 0.033 DBMET01200 | DBMET01200 | |
| 0.044 | 0.237 | 0.118 | Xanthine oxidase inhibitor | 0.118 0.048 DBMET01201 | DBMET01201 | |
| 0.016 | 0.214 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.028 DBMET01200 | DBMET01200 | |
| 0.014 | 0.214 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.036 DBMET01201 | DBMET01201 | |
| 0.018 | 0.219 | 0.067 | Glutamate (mGluR group III) agonist | 0.067 0.016 DBMET01201 | DBMET01201 | |
| 0.041 | 0.244 | 0.091 | Interleukin 1 beta converting enzyme inhibitor | 0.091 0.07 DBMET01201 | DBMET01201 | |
| 0.017 | 0.221 | 0.053 | Diacylglycerol O-acyltransferase inhibitor | 0.053 0.033 DBMET01201 | DBMET01201 | |
| 0.043 | 0.249 | 0.094 | Bile acid receptor antagonist | 0.094 0.062 DBMET01201 | DBMET01201 | |
| 0.005 | 0.213 | 0.024 | Kynurenine 3 monooxygenase inhibitor | 0.024 0.021 DBMET01201 | DBMET01201 | |
| 0.071 | 0.281 | 0.253 | Hepatoprotectant | 0.253 0.042 DBMET00087 0.133 0.13 DBMET01201 | DBMET00087 | |
| 0.062 | 0.299 | 0.146 | Hexokinase inhibitor | 0.146 0.084 DBMET01201 | DBMET01201 | |
| 0.046 | 0.287 | 0.105 | Toll-Like receptor 4 antagonist | 0.105 0.063 DBMET00087 | DBMET00087 | |
| 0.018 | 0.26 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.037 DB14132 | DB14132 | |
| 0.052 | 0.297 | 0.105 | CDC-like kinase 3 inhibitor | 0.105 0.069 DBMET01200 | DBMET01200 | |
| 0.003 | 0.255 | 0.264 | Prostacyclin agonist | 0.264 0.002 DBMET01201 | DBMET01201 | |
| 0.006 | 0.26 | 0.032 | Adenosine A3 receptor agonist | 0.032 0.005 DB14132 | DB14132 | |
| 0.082 | 0.343 | 0.408 | Hypoglycemic | 0.272 0.064 DBMET00087 0.171 0.145 DBMET01200 0.408 0.026 DBMET01201 | DBMET01201 | |
| 0.02 | 0.288 | 0.048 | Glucose-6-phosphate translocase inhibitor | 0.048 0.044 DBMET00087 | DBMET00087 | |
| 0.007 | 0.293 | 0.31 | Nicotinic acid receptor agonist | 0.31 0.002 DB14132 | DB14132 | |
| 0.005 | 0.292 | 0.114 | Purinergic P2X agonist | 0.114 0.003 DB14132 | DB14132 | |
| 0.038 | 0.325 | 0.144 | DNA polymerase I inhibitor | 0.113 0.074 DBMET00087 0.144 0.053 DBMET01201 | DBMET01201 | |
| 0.016 | 0.304 | 0.147 | CDC25B inhibitor | 0.147 0.007 DBMET01201 | DBMET01201 | |
| 0.015 | 0.307 | 0.121 | Monophenol monooxygenase inhibitor | 0.121 0.061 DBMET01201 | DBMET01201 | |
| 0.02 | 0.315 | 0.086 | Factor IXa inhibitor | 0.086 0.014 DBMET00087 | DBMET00087 | |
| 0.017 | 0.318 | 0.039 | Calcium-independent phospholipase A2 inhibitor | 0.039 0.012 DBMET01201 | DBMET01201 | |
| 0.011 | 0.316 | 0.145 | TRPA1 antagonist | 0.145 0.01 DB14132 | DB14132 | |
| 0.021 | 0.329 | 0.146 | 5-Lipoxygenase inhibitor | 0.146 0.039 DBMET01201 | DBMET01201 | |
| 0.008 | 0.326 | 0.095 | Antineoplastic antibiotic | 0.095 0.048 DBMET00087 | DBMET00087 | |
| 0.058 | 0.386 | 0.312 | Antioxidant | 0.312 0.058 DBMET00087 | DBMET00087 | |
| 0.01 | 0.34 | 0.087 | Plasminogen activator inhibitor antagonist | 0.087 0.013 DBMET01201 | DBMET01201 | |
| 0.024 | 0.358 | 0.081 | Somatostatin 1 agonist | 0.081 0.05 DBMET01200 | DBMET01200 | |
| 0.004 | 0.339 | 0.035 | HMG CoA reductase inhibitor | 0.035 0.023 DBMET01201 | DBMET01201 | |
| 0.039 | 0.377 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.071 DBMET00087 | DBMET00087 | |
| 0.003 | 0.342 | 0.042 | Free fatty acid receptor 1 agonist | 0.042 0.005 DBMET01201 | DBMET01201 | |
| 0.012 | 0.352 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | 0.045 0.036 DBMET00086 | DBMET00086 | |
| 0.022 | 0.398 | 0.41 | Bronchodilator | 0.41 0.005 DB14132 | DB14132 | |
| 0.009 | 0.389 | 0.219 | Selectin antagonist | 0.219 0.01 DBMET00087 0.063 0.047 DBMET01201 | DBMET00087 | |
| 0.088 | 0.471 | 0.393 | Apoptosis antagonist | 0.393 0.04 DBMET01201 | DBMET01201 | |
| 0.005 | 0.389 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 DBMET01200 | DBMET01200 | |
| 0.024 | 0.414 | 0.084 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.084 0.057 DBMET01200 | DBMET01200 | |
| 0.074 | 0.464 | 0.301 | Immunomodulator | 0.301 0.082 DB14132 | DB14132 | |
| 0.075 | 0.468 | 0.344 | Toll-Like receptor 7 agonist | 0.248 0.149 DB14132 0.313 0.102 DBMET00087 0.344 0.085 DBMET01201 | DBMET01201 | |
| 0.005 | 0.405 | 0.013 | Adenosine A2b receptor agonist | 0.013 0.012 DB14132 | DB14132 | |
| 0.008 | 0.412 | 0.055 | Neuraminidase inhibitor | 0.055 0.05 DBMET00087 | DBMET00087 | |
| 0.075 | 0.483 | 0.319 | Sodium/bile acid cotransporter inhibitor | 0.319 0.063 DBMET01201 | DBMET01201 | |
| 0.07 | 0.48 | 0.339 | Toll-Like receptor agonist | 0.239 0.158 DB14132 0.317 0.1 DBMET00087 0.339 0.088 DBMET01201 | DBMET01201 | |
| 0.03 | 0.445 | 0.378 | Angiogenesis stimulant | 0.378 0.026 DBMET00087 | DBMET00087 | |
| 0.008 | 0.424 | 0.082 | Phosphodiesterase IV inhibitor | 0.082 0.059 DB14132 | DB14132 | |
| 0.013 | 0.44 | 0.105 | Protein kinase B gamma inhibitor | 0.068 0.06 DB14132 0.105 0.03 DBMET01200 | DBMET01200 | |
| 0.004 | 0.457 | 0.04 | Adenosine A1 receptor agonist | 0.04 0.007 DB14132 | DB14132 | |
| 0.036 | 0.49 | 0.141 | Nitric oxide antagonist | 0.141 0.103 DBMET00087 | DBMET00087 | |
| 0.01 | 0.494 | 0.053 | Sphingosine 1-phosphate receptor 5 agonist | 0.053 0.038 DBMET01201 | DBMET01201 | |
| 0.032 | 0.535 | 0.325 | Platelet adhesion inhibitor | 0.201 0.071 DBMET00087 0.325 0.026 DBMET01201 | DBMET01201 | |
| 0.011 | 0.515 | 0.057 | Phosphodiesterase 7A inhibitor | 0.057 0.027 DB14132 | DB14132 | |
| 0.015 | 0.523 | 0.14 | Cell adhesion molecule inhibitor | 0.14 0.017 DBMET01201 | DBMET01201 | |
| 0.037 | 0.545 | 0.086 | Interleukin 12 antagonist | 0.086 0.081 DBMET01200 | DBMET01200 | |
| 0.005 | 0.519 | 0.051 | Peroxisome proliferator-activated receptor delta antagonist | 0.051 0.009 DBMET01201 | DBMET01201 | |
| 0.079 | 0.599 | 0.282 | Interleukin 2 agonist | 0.271 0.097 DBMET00087 0.262 0.106 DBMET01200 0.282 0.088 DBMET01201 | DBMET01201 | |
| 0.046 | 0.57 | 0.176 | Growth hormone agonist | 0.176 0.07 DBMET01200 0.136 0.1 DBMET01201 | DBMET01200 | |
| 0.006 | 0.534 | 0.266 | Protein-tyrosine phosphatase 1B inhibitor | 0.266 0.014 DBMET01201 | DBMET01201 | |
| 0.008 | 0.539 | 0.293 | Phosphodiesterase V inhibitor | 0.293 0.005 DB14132 | DB14132 | |
| 0.025 | 0.563 | 0.177 | Phosphodiesterase 7B inhibitor | 0.177 0.014 DB14132 | DB14132 | |
| 0.008 | 0.549 | 0.301 | Phosphodiesterase 5A inhibitor | 0.301 0.004 DB14132 | DB14132 | |
| 0.02 | 0.561 | 0.05 | Alpha 1b adrenoreceptor agonist | 0.05 0.036 DBMET00086 | DBMET00086 | |
| 0.02 | 0.563 | 0.223 | Free radical scavenger | 0.223 0.082 DBMET00087 | DBMET00087 | |
| 0.004 | 0.547 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.018 DBMET01201 | DBMET01201 | |
| 0.074 | 0.621 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.095 DBMET00087 | DBMET00087 | |
| 0.021 | 0.571 | 0.172 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.172 0.102 DBMET01200 | DBMET01200 | |
| 0.017 | 0.574 | 0.051 | Parathyroid hormone antagonist | 0.051 0.02 DBMET01200 | DBMET01200 | |
| 0.015 | 0.577 | 0.153 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.153 0.117 DBMET01200 | DBMET01200 | |
| 0.017 | 0.581 | 0.126 | Dual specificity phosphatase 3 inhibitor | 0.126 0.121 DBMET01201 | DBMET01201 | |
| 0.006 | 0.579 | 0.08 | Phosphodiesterase VII inhibitor | 0.08 0.026 DB14132 | DB14132 | |
| 0.003 | 0.577 | 0.045 | GP IIb/IIIa receptor antagonist | 0.045 0.037 DBMET01201 | DBMET01201 | |
| 0.062 | 0.641 | 0.348 | Antiinflammatory | 0.277 0.237 DBMET00087 0.348 0.174 DBMET01201 | DBMET01201 | |
| 0.014 | 0.598 | 0.506 | Uric acid excretion stimulant | 0.506 0.003 DB14132 0.131 0.032 DBMET01201 | DB14132 | |
| 0.004 | 0.594 | 0.124 | Prostaglandin D2 agonist | 0.124 0.002 DBMET01201 | DBMET01201 | |
| 0.004 | 0.595 | 0.117 | Prostaglandin EP2 antagonist | 0.117 0.015 DBMET01201 | DBMET01201 | |
| 0.014 | 0.608 | 0.133 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.133 0.103 DBMET01200 | DBMET01200 | |
| 0.009 | 0.623 | 0.138 | Cyclin-dependent kinase inhibitor | 0.138 0.063 DB14132 | DB14132 | |
| 0.009 | 0.624 | 0.039 | Purinergic P2Y2 antagonist | 0.039 0.017 DB14132 | DB14132 | |
| 0.005 | 0.642 | 0.182 | Cyclin-dependent kinase 2 inhibitor | 0.182 0.028 DB14132 | DB14132 | |
| 0.016 | 0.662 | 0.201 | Cell adhesion inhibitor | 0.201 0.024 DBMET01201 | DBMET01201 | |
| 0.009 | 0.671 | 0.268 | Phosphodiesterase inhibitor | 0.268 0.019 DB14132 | DB14132 | |
| 0.007 | 0.697 | 0.299 | Protein-tyrosine phosphatase inhibitor | 0.299 0.019 DBMET01201 | DBMET01201 | |
| 0.004 | 0.7 | 0.199 | Cyclin E inhibitor | 0.199 0.005 DB14132 | DB14132 | |
| 0.004 | 0.7 | 0.206 | Cyclin E1 inhibitor | 0.206 0.005 DB14132 | DB14132 | |
| 0.004 | 0.701 | 0.172 | Phosphodiesterase 4A inhibitor | 0.172 0.009 DB14132 | DB14132 | |
| 0.004 | 0.717 | 0.07 | Urokinase inhibitor | 0.07 0.024 DBMET01200 | DBMET01200 | |
| 0.015 | 0.73 | 0.062 | DNA helicase inhibitor | 0.062 0.024 DBMET01201 | DBMET01201 | |
| 0.004 | 0.723 | 0.063 | Cyclin B inhibitor | 0.063 0.028 DB14132 | DB14132 | |
| 0.003 | 0.736 | 0.145 | Prostaglandin D2 antagonist | 0.145 0.004 DBMET01201 | DBMET01201 | |
| 0.002 | 0.748 | 0.022 | Thyroid hormone alpha agonist | 0.022 0.005 DBMET01201 | DBMET01201 | |
| 0.004 | 0.755 | 0.115 | Aldose reductase inhibitor | 0.115 0.015 DBMET01201 | DBMET01201 | |
| 0.009 | 0.798 | 0.04 | Glutamate (mGluR8) antagonist | 0.04 0.017 DBMET01201 | DBMET01201 | |
| 0.004 | 0.795 | 0.128 | Phosphodiesterase 2A inhibitor | 0.128 0.005 DB14132 | DB14132 | |
| 0.003 | 0.804 | 0.137 | Phosphodiesterase II inhibitor | 0.137 0.006 DB14132 | DB14132 | |
| 0.004 | 0.814 | 0.146 | Phosphodiesterase III inhibitor | 0.146 0.01 DB14132 | DB14132 | |
| 0.009 | 0.823 | 0.113 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.113 0.108 DBMET01200 | DBMET01200 | |
| 0.004 | 0.819 | 0.223 | Prostaglandin antagonist | 0.223 0.006 DBMET01201 | DBMET01201 | |
| 0.012 | 0.849 | 0.537 | Cyclophilin D inhibitor | 0.537 0.04 DBMET00087 0.535 0.041 DBMET01201 | DBMET00087 | |
| 0.004 | 0.863 | 0.073 | Phosphodiesterase 3A inhibitor | 0.073 0.066 DB14132 | DB14132 | |
| 0.003 | 0.911 | 0.119 | Phosphodiesterase 4D inhibitor | 0.119 0.029 DB14132 | DB14132 | |
| 0.003 | 0.932 | 0.176 | Phosphodiesterase 4C inhibitor | 0.176 0.005 DB14132 | DB14132 | |
| 0.004 | 0.942 | 0.54 | Nicotinic acid receptor 1 agonist | 0.54 0.001 DB14132 | DB14132 | |
| 0.006 | 0.949 | 0.149 | Insulin secretagoues | 0.149 0.075 DBMET01201 | DBMET01201 | |
| 0.003 | 0.96 | 0.447 | Nicotinic acid receptor 2 agonist | 0.447 0.001 DB14132 | DB14132 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |